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ABSTRACT 
The Na+/Ca2+ exchanger 1 (NCX1), which is highly expressed in the hippocampus, 
cortex, and amygdala, regulates Akt1 phosphorylation. Since Akt1 is part of the 
PTEN/Akt1/CREB signaling pathway, which participates in synaptic plasticity and 
long-term memory, we investigated whether NCX1 expression/activity might also be 
involved in some hippocampal-dependent learning and memory processes. To test 
this hypothesis, we used two genetically-modified mice to selectively overexpress 
(NCX1.4over) or downregulate (NCX1ko) NCX1 in hippocampal, cortical, and amygdala 
neurons and a newly synthesized selective NCX1 stimulating compound, named CN-
PYB2. Both NCX1.4over and CN-PYB2-treated mice showed increased 
phosphorylated CaMKII levels in the hippocampus and improved long-term spatial 
learning and memory performance. By contrast, NCX1ko mice displayed a decrease 
in both. In addition, both NCX1.4over and CN-PYB2-treated mice also displayed an 
increase in context-dependent anxiety. 
Altogether, these results demonstrate that neuronal NCX1 participates in 
hippocampal-amygdala memory consolidation and promote anxiety behavior. 
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1. INTRODUCTION 
 
1.1 MEMORY PROCESS 
1.1.1 HISTORY OF THE RESEARCH IN SYNAPTIC PLASTICITY AND MEMORY 
CONSOLIDATION 
Memory is defined as the capacity of brain to storage new pieces of information. The 
memory process is not a single faculty of mind but it is composed by multiple kinds of 
learning, each one processed by different brain regions. Studies in memory 
classification began in 1804 when Mine de Biran described for the first time three 
types of memories: (a) mechanical memory, (b) sensitive memory and (c) 
representative memory (Maine de Biran, 1929). In 1890 James W. explained in two 
different chapters memory and habits; in 1923 McDougall distinguished between 
explicit and implicit recognition and Tolman in 1948 reaching the theory that there is 
more than one kind of learning (James, 1890; Tolman, 1948). However, the main 
milestone in the memory research is represented by the case of the patient H.M., a 
severely amnesic man that was able to learn hand-eye coordination skill in absence 
of most of brain structure related to memory (Milner et al., 1968). Thanks to the 
increasing research in memory, to date it is widely accepted that it can be mainly 
classified in declarative and non-declarative memories. Declarative memory is the 
capacity of conscious to recollect fact and events and depending on structures in the 
medial temporal lobe and midline diencephalon (Squire et al., 2004). Non-declarative 
memory is referred to the collection of non-conscious abilities including simple 
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conditioning, priming, skills and habits, each one dependent on amygdala, neocortex 
and striatum respectively (Squire, 1992). 
1.1.2 BRAIN STRUCTURES INVOLVED IN MEMORY FORMATION 
To date, it is known that the most important cerebral regions involved in memory 
formation are the medial temporal lobe of cerebral cortex, amygdala, hippocampus, 
cingulate gyrus, thalamus and hypothalamus. The brain structures responsible of the 
“storage information” are interrelated through neural circuits. The cerebral cortex is 
subdivided into four lobes each one participates in different kinds of learning. The 
frontal lobe, known as prefrontal cortex, is involved in conscious though and in higher 
mental functions such as decision-making and it is important in processing short-term 
memory and in retaining long-term memories (Matthews, 2015). The parietal lobe 
integrates sensory information and participates in determining spatial sense and 
navigation; temporal lobe is involved in the senses of smell and sound and in 
processing of semantics and the occipital lobe is mainly involved in the sense of 
sight. The amygdala is essentially associated to memory consolidation, emotional 
learning and fear mediated responses (Roozendaal et al., 2009). Finally, the 
hippocampus is important for the conversion of short-term to long-term memory 
(Wong, 1997). Interestingly, hippocampus is divided in two subregions dorsal and 
ventral that are differently involved in several cognition processes. In particular, 
dorsal hippocampus participates in the spatial memory, since it is enriched with 
“place cells” that are responsible for modeling of cognitive maps representing the 
surrounding environment (Moser et al., 2015; Cobar et al., 2017). On the other hand, 
the ventral hippocampus is involved in contextual anxiety since it is enriched with 
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“anxiety cells”, that increase their cytosolic Ca2+ concentration ([Ca2+]i) in response to 
anxiety-dependent contexts (Jimenez et al., 2018). 
 
1.1.3 BIOCHEMISTRY OF MEMORY: LONG TERM POTENTIANTION (LTP) AND 
MOLECULAR PATWAYS  
The molecular storage of learning and memory in the brain is highly correlated to the 
changes in the strength and numbers of connections among neurons. This 
phenomenon is called “synaptic plasticity” and the potentiation of synaptic connection 
responds differently to specific stimulations (HEBB and KONZETT, 1949). Studies in 
hippocampal neurons suggest that a weak train of stimulations induces post-tetanic 
potentiation (PTP), whereas an intermediate train of stimulations induces short term 
potentiation (STP) and a strong train of stimulations induces the long-term 
potentiation (LTP) (Bliss and Collingridge, 1993). The effect of PTP lasts in the range 
of several minutes, STP decays within 1 hour and LTP is sustained for a much longer 
period (Bliss and Gardner-Medwin, 1973; Walters and Byrne, 1984; Zucker and 
Regehr, 2002). The LTP could be delivered by a “tetanus” which means a train of 50-
100 stimuli at 100 Hz (Figurov et al., 1996), by a more modest stimulus such as 
“theta-burst stimulation” (several bursts of 4 shocks at 100 Hz delivered at an interval 
of 200 ms) (Larson et al., 1986) or by a “primed burst stimulation” (a single priming 
stimulus followed at 200 ms by 4 shocks at 100 Hz) (Rose and Dunwiddie, 1986; 
Otto et al., 1991). The LTP is characterized by three basic properties: cooperativity, 
means the intensity and pattern of tetanic stimulation; associativity, the input could be 
active at the same or separate time; and input-specificity, LTP could occur only in a 
synapse of a neuron. The effects of LTP are expressed in the potentiation of long-
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term memory (Lynch, 2004). The molecular mechanisms occurred during LTP 
process are dependent on the stimulation of NMDA glutamate receptors, Ca2+ entry 
and the activation of specific molecular pathways (Miyamoto, 2006). Studies 
performed in Ca2+/Calmodulin-dependent protein kinase II (CaMKII) mutant mice, or 
experiments performed on hippocampal slices after a theta-burst stimulation suggest 
a crucial role of the active form of the CaMKII during LTP (Silva et al., 1992; 
Fukunaga et al., 1993; Fukunaga et al., 1995). The generation of knockout mice for 
the cyclic AMP responsive element binding protein (CREB) suggests that the 
phosphorylation and activation of this protein is important for the induction of the LTP 
(Bourtchuladze et al., 1994) since it promotes the transcription of genes involved in 
the consolidation of synaptic plasticity (Lüscher et al., 2000). Moreover, it is known 
that the activation CREB could be directly regulated by CaMKII phosphorylation (Sun 
et al., 1994) or by AKT phosphorylation (Du and Montminy, 1998). At present, both 
CaMKII and CREB are considered as molecular markers of memory (Mizuno et al., 
2002; Kandel, 2012). 
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1.2 THE Na+ AND Ca2+ EXCHANGER (NCX)  
1.2.1 BIOCHEMICAL CHARACTHERIZATION OF NCX 
The Na+ and Ca2+ exchanger (NCX) is an important plasma membrane transporter 
that mediates the antiporter of Na+ and Ca2+ (Reeves and Hale, 1984; Fujioka et al., 
2000; Kang and Hilgemann, 2004). The exchanger is expressed in three isoforms 
NCX1, NCX2 and NCX3, each one is coded by three different genes (Nicoll et al., 
1990; Li et al., 1994; Nicoll et al., 1996). NCX1 is composed of 938 amino acids and 
has a theoretical molecular mass of 120 kDa, NCX2 and NCX3 consists of 921 and 
927 amino acids with a predicted molecular weight of 102 and 105 kDa, respectively.  
It is widely accepted that NCX mediates the antiporter of Ca2+ and Na+ ions across 
plasma membrane with a stoichiometry 1:3, even if it could vary from 1:1 to 1:4 
depending on intracellular Na+ and Ca2+ concentration (Blaustein and Lederer, 1999; 
Philipson and Nicoll, 2000). NCX could operate in forward mode by coupling 
extrusion of Ca2+ to the influx of Na+ and in reverse mode by mediating the extrusion 
of Na+ and the intrusion of Ca2+ (Annunziato et al., 2004). 
 
1.2.2 TISSUE-SPECIFIC DISTRIBUTIONS OF NCX ISOFORMS 
The three NCX isoforms show a peculiar distribution in different tissues. In particular, 
the isoform NCX1 is expressed in brain, heart, skeletal muscle, smooth muscle, 
kidney, eye, secretory and blood cells, whereas NCX3 has been found in neuronal 
and skeletal muscle tissues (Quednau et al., 1997) and NCX2 is predominantly 
expressed in CNS (Jeon et al., 2003). 
NCX1, NCX2 and NCX3 genes are differently expressed in neurons and glia of all 
areas of the central nervous system (CNS) (Papa et al., 2003). In particular, 
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pyramidal neurons of motor cortex layer III and V are enriched in NCX1, whereas 
NCX2 is intensively localized in the somatosensory cortical area. 
Immunohistochemistry experiments revealed differential expression of NCX isoforms 
in hippocampal subregions. NCX1 isoform is mainly localized in the granule cell layer 
and in dentate gyrus, the area of hippocampus receiving cortical projections; both 
NCX1 and NCX3 are expressed in the CA3 region, whereas only NCX3 is mainly 
found in the CA1 region. In the amygdala both NCX1 and NCX3 are localized in the 
lateral nucleus and basolateral nuclei (Canitano et al., 2002). 
 
1.2.3 THE IMPORTANCE OF NCX UNDER PATHOLOGICAL AND 
PHISYOLOGICAL CONDITIONS  
The Na+ and Ca2+ exchanger is involved under different physiological and 
pathological conditions by regulating sodium and calcium homeostasis. Under 
physiological condition, for example, NCX is important in the contraction of cardiac 
myocytes (Bridge et al., 1990; Crespo et al., 1990), in mastocytes it participates in 
the cellular activation (Aneiros et al., 2005), in neurons it is involved in action 
potential and neurotransmitters release, and in glia it could regulate cellular activation 
(Boscia et al., 2009) and oligodendrocyte differentiation (Boscia et al., 2011). The Na+ 
and Ca2+ exchanger is also involved in pathological diseases characterized by a 
dysregulation of Ca2+ homeostasis, such as stroke, Alzheimer, Parkinson and 
multiple sclerosis diseases (Herchuelz et al., 2002; Pannaccione et al., 2002; 
Molinaro et al., 2008b). In stroke, it has been discovered that an increase in NCX 
activity could limit the severity of ischemic damage by coping with the increase of 
[Ca2+]i (Annunziato et al., 2007). The analysis of NCX isoforms in synaptosomal 
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preparation from parietal cortex of normal aged controls and late stage Alzheimer’s 
disease patient revealed an upregulation of NCX2 and a downregulation of NCX3 
suggesting a possible role of this protein in the progression of the disease (Sokolow 
et al., 2011). 
NCX2 and NCX3 plasmalemmal proteins regulate the mitochondrial protein kinase 
PINK1, involved in Parkinson disease, and their activity prevent the 
neurodegeneration of dopaminergic neurons by regulating the accumulation of 
mitochondrial [Ca2+]i (Wood-Kaczmar et al., 2013). In multiple sclerosis NCX have 
been implicated in the impairment of axonal and neuronal functions. 
 
1.2.4 PHARMACOLOGICAL MODULATION NCX 
Since the discovery of the roles of NCX under different physiological and pathological 
conditions, many studies have been dedicated to its pharmacological modulation 
(Annunziato et al., 2004). Several organic and inorganic compounds have been 
identified as modulators of NCX activity, however most of them are inhibitors 
(Watano et al., 1999; Iwamoto et al., 2004; Secondo et al., 2009b; Molinaro et al., 
2016), subdivided in 16 chemical classes, or possesses some nonspecific effects on 
others ion channels or receptors (Pintado et al., 2000; Reuter et al., 2002b). A new 
cell penetrating peptide, consistent of the endogenous region 562-688aa of the 
exchanger, was developed to prevent, by steric hindrance, the interaction between 
P1 and XIP domains involved in the autoinhibition of the exchanger (Molinaro et al., 
2015). Thus, this regulatory peptide exerts a stimulatory effect on NCX1 activity. 
Recently, a new chemical compound named neurounina-1 (Molinaro et al., 2013) 
was synthesized by the modification of the chemical structure of SM-15811, one of 
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the most potent inhibitor of NCX activity (Hasegawa et al., 2003). Neurounina-1 is 
able to increase NCX1 and NCX2 activity, in both forward and reverse modes of 
operation, with an EC50 in the low nanomolar range, whereas it has no effects on 
NCX3 activity. This new compound shows a neuroprotective effect on experimental 
model of cerebral ischemia. In order to obtain drugs selective for each NCX isoform, 
twenty new compounds were generated by different modifications on the chemical 
backbone of neurounina-1. In the present work these compounds were screened for 
their effects on NCX1, NCX2 and NCX3 activity. 
 
1.2.5 NCX GENETIC MODIFIED MICE 
In order to study the role of all three NCX isoforms under some physiological or 
pathological conditions NCX1, NCX2 and NCX3 genetically modified mice were 
generated. In 2000, four independent laboratories generated NCX1 knock-out mice, 
but this mouse dye in utero 9.5 days post-coitum because of the loss of spontaneous 
heartbeat (Cho et al., 2000; Wakimoto et al., 2000; Koushik et al., 2001; Reuter et al., 
2002a) Then, in 2004, Henderson et al., overcame this limitation with the generation 
of a conditioned NCX1 knock-out mouse by means of Cre/LoxP technique. The 
knock-out of NCX2 or NCX3 isoform is compatible with life and survive until old age. 
Further studies in NCX1 genetic modified mice show that the overexpression of 
NCX1 in cortex and hippocampus reduces the ischemic volume and ameliorates 
focal and general deficits after transient middle cerebral artery occlusion, whereas, 
opposite results are obtained in NCX1 knockout mice. Moreover, the overexpression 
of NCX1 is accompanied by an enhancement of phosphorylation levels of Akt1 in 
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neuronal cells in both in vitro and in vivo models (Secondo et al., 2015; Molinaro et 
al., 2016; Secondo et al., 2018b).  
Moreover, since NCX plays a role in the regulation of [Ca2+]i concentration at synaptic 
level of hippocampal neurons (Reuter and Porzig, 1995; Bouron and Reuter, 1996) 
the role of NCX2 and NCX3 in learning and memory performance were investigated 
by the use of NCX2 and NCX3 knock-out mice, respectively. The deletion of NCX2 in 
hippocampal neurons significantly prolongs the time required for clearance of 
increased [Ca2+]i and consequently increases LTP and synaptic plasticity 
consolidation. Furthermore, NCX2 knock-out mice show an improvement of their 
performance in hippocampal-depended learning and memory tasks such as Barnes 
maze, contextual conditioning and novel object recognition test (Jeon et al., 2003). 
On the other hand, the knock-out of NCX3 worsens LTP and impairs basal synaptic 
transmission in hippocampus. For this reason, NCX3 knockout mice show a 
reduction of CaMKII expression and a reduction of learning and memory 
performance in Barnes maze, novel object and context depended fear conditioning 
assay (Molinaro et al., 2011).  
To date, there is no evidence of the role played by NCX1 in learning and memory 
performance, but previous studies show that NCX1 increases the phosphorylation of 
Akt, a protein involved in signalling pathways important for the long-term potentiation 
and in the improvement of memory consolidation (Sui et al., 2008; Giese and Mizuno, 
2013). In the present work we analyse the effects of NCX1 on learning and memory 
tasks by modulating its activity with a new selective activator, and its expression with 
the generation of two genetic modified mice that, upon tamoxifen administration show 
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a selective overexpression, or knockout, of NCX1 isoform (Molinaro et al., 2016) in 
neurons of hippocampus, cortex and amygdala. 
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2. AIMS 
The Na+/Ca2+ exchanger 1 (NCX1) participates in the maintenance of cytosolic Ca2+ 
homeostasis and is highly expressed in the hippocampus, cortex, and amygdala 
(Canitano et al., 2002; Papa et al., 2003), three brain regions involved in spatial 
learning and memory and social behavior. This appear to be very interesting since: 
(a) NCX1 expression/activity regulates Akt1 phosphorylation in neuronal cells 
(Secondo et al., 2015; Molinaro et al., 2016; Secondo et al., 2018a); (b) NCX1 might 
increase CREB phosphorylation via the PTEN/Akt/CREB signaling pathway by 
increasing Akt1 phosphorylation; (c) NCX1 might affect calmodulin kinase II (CaMKII) 
activation via the Ca2+/calmodulin/CaMKII pathway by regulating cytosolic neuronal 
Ca2+ clearance; (d) activation of both CaMKII and CREB proteins plays a pivotal role 
in spatial learning and memory performance and anxiety behavior (Carlezon et al., 
2005; Lo Iacono and Gross, 2008). 
On the basis of these assumptions, we investigated the role of NCX1 in spatial 
learning, memory and anxiety behavior by means of two complementary strategies: 
(i) two genetically modified mouse strains for NCX1 and (ii) the design and synthesis 
of a newly compound, named CN-PYB2, that selectively increases NCX1 activity. In 
particular, upon tamoxifen administration, the two genetically modified mouse strains, 
display a selective increase (NCX1.4over), or decrease (NCX1ko), in NCX1 expression 
in hippocampal, cortical and amygdala neurons (Molinaro et al., 2016).  
All genetically modified mice for NCX1 and CN-PYB2-treated C57BL/6 mice were 
analyzed in several hippocampal-dependent tasks to evaluate the physiological role 
of NCX1 in promoting spatial learning, memory, and anxiety behavior, and in 
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activating of some molecular markers involved in synaptic plasticity including CaMKII 
and CREB.  
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3. MATERIALS AND METHODS 
3.1 PROCEDURES FOR THE SYNTHESIS OF 5-(2-CHLOROPHENYL)-7-NITRO-1-
(PYRROLIDIN-1-YLMETHYL)-1H-BENZO[E][1,4]DIAZEPIN-2(3H)-ONE 2,2,2-
TRIFLUOROACETATE (COMPOUND 2)  
The compound was obtained as following the synthetic procedure reported for 
neurounina-1 (Molinaro et al., 2013), starting from clonazepam and pyrrolidine. Yield 
67.8%. ESI-MS calcd for C20H19ClN4O3 398,8 found [M+H]+ 400,5. Final compound 
was converted to the corresponding trifluoroacetate salt by dissolving in 0.1% 
trifluoroacetic acid (TFA) in H2O/acetonitrile (60:40 [v/v]). Finally, the obtained 
solution was frozen and lyophilized to yield the desired salt (mp 169.1 °C). The final 
product was analyzed by NMR spectroscopy. In particular, results showed 1H NMR 
(400 MHz, DMSO-d6) δ 1.80-1.90 (m, 4H), 2.00-2.10 (m, 4H), 3.75 (s, 2H), 4.27 (s, 
2H), 7.47-7.57 (m, 4H), 7.78 (s, 1H), 7.82 (d, 1H), 8.41 (d, 1H); 13C-NMR (400 MHz, 
DMSO-d6): δ 168.69; 168.30; 143.95; 142.37; 137.79; 132.37; 132.33; 132.26; 
130.25; 127.98; 127.72; 127.28; 125.45; 122.96; 60.70; 55.39; 54.35; 22.82; where 
"s" was used for singlet and "m" was used for multiplet. The 1H and 13C NMR spectra 
were recorded on a Varian Mercury Plus 400 MHz instrument (Varian Inc., Palo Alto, 
CA). Purity of the product (>99.5%) was assessed by analytical reversed-phase high-
performance liquid chromatography (HPLC) using the conditions previously reported 
in literature for neurounina-1 (Molinaro et al., 2013). 
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3.2 EXPERIMENTAL GROUPS 
Both genetically modified mouse lines, viz, neuronal specific NCX1.4 overexpressing 
mice (NCX1.4over) and NCX1 knock-out (NCX1ko) mice, were generated by our 
research group as previously described (Molinaro et al., 2016). Wild-type C57BL/6 
mice were purchased from Charles River (Italy). NCX1ko, NCX1.4over and C57BL/6 
mouse strains, aged 8–12 weeks and weighing 20–25 g, were housed under diurnal 
lighting conditions (light 6:00 a.m. to 6:00 p.m.).  
In this study, 105 genetically modified and 75 C57BL/6 male mice were used for 
experimental procedures. In particular, animals for each experimental group were 
randomly selected from the respective mouse genotypes. Fifteen animals, randomly 
selected for each genotype, were considered to be sufficient per each experimental 
group to demonstrate any variation in behavioral tests.  
To induce genomic DNA recombination, both NCX1ko, NCX1.4over were treated with 
tamoxifen for 5 days as previously reported (Molinaro et al., 2016) and used after at 
least one week of drug wash-out. C57BL/6 mice were treated with saline solution 
(vehicle) or with 32 µg/kg of Compound 2 solution by i.p. injections. In vivo toxicity 
was evaluated by a single i.p. administration of a saline solution containing 32 µg/kg 
of Compound 2. Variations of body weight, temperature, and abnormal behavior was 
monitored for 15 days. 
All experiments were carried out in blind manner, the people who performed the 
experiments and analyzed the data were not aware of the pharmacological 
treatment. All protocols and procedures of the handling of animals were performed 
on male mice according to the international guidelines for animal research and 
approved by the Animal Care Committee of “Federico II” University of Naples, Italy. 
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3.3 MEASUREMENT OF Na+-DEPENDENT 45Ca2+ EFFLUX 
NCX-mediated 45Ca2+ efflux was measured as previously described (Molinaro et al., 
2013). Briefly, cells were loaded with 5 µM 45Ca2+ (80 MBq/ml) together with 1 µM 
ionomycin for 60 seconds in normal Krebs (in mM): 5.5 KCl, 145 NaCl, 1.2 MgCl2, 
1.5 CaCl2, 10 glucose, and 10 Hepes-NaOH (pH 7.4). Next, cells were exposed 
either to a Ca2+ and Na+-free solution—a condition that blocks both 
intracellular 45Ca2+ efflux and extracellular Ca2+ influx— or to a Ca2+-free plus 0.5 mM 
EGTA containing 145 mM Na+, a condition that promotes 45Ca2+ efflux. Thapsigargin 
(1 µM) was present in both solutions. 45Ca2+ efflux was started by using Ca2+-free, 
Na+-containing solution plus 0.5 mM EGTA. Cells were exposed to this solution, 
which promotes 45Ca2+ efflux, for 10 seconds. At the time chosen (10 seconds), a 
very low efflux was detected in wild-type BHK cells. Na+-dependent 45Ca2+ efflux was 
estimated by subtracting 45Ca2+ efflux in Ca2+- and Na+-free solution from that in 
Ca2+-free solution. Cells were subsequently lysed with 0.1 N NaOH, and aliquots 
were taken to determine radioactivity. The EC50 values for Compound 2 were 
obtained by fitting the data with the equation a + b x exp(-x/t), where a is the maximal 
response, b is the basal response, x is the drug concentration, and t is the EC50. 
 
3.4 PROTEIN EXPRESSION ANALYSIS 
Whole-cell protein extracts from adult hippocampus or cortex were obtained and 
processed as previously described (Molinaro et al., 2008a). Briefly, nitrocellulose-
membranes were incubated with anti-CREB (mouse monoclonal, 1:1000, Cell 
Signaling), anti-pCREB Ser133 (rabbit polyclonal, 1:1000 Millipore), anti-Phospho-
CaM Kinase II T286 (rabbit polyclonal, 1:1000, abcam), anti-Phospho-CaM Kinase II 
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T305 (rabbit polyclonal, 1:1000, Bioss antibodies) or anti-Tubulin (mouse 
monoclonal, 1:10.000, Sigma) antibodies. 
These nitrocellulose-membranes were first washed with 0.1% Tween 20, and then 
incubated with the corresponding secondary antibodies for 1h (GE Healthcare Bio-
Sciences). Immunoreactive bands were detected with electrochemiluminescence (GE 
Healthcare Bio-Sciences). The optical density of the bands (normalized with Tubulin 
or Creb) was determined by Chemi-Doc Imaging System (Bio-Rad). 
 
3.5 CELL CULTURES 
Baby hamster kidney (BHK) cells stably transfected with canine cardiac NCX1.1, rat 
brain NCX2.1, and NCX3.3 were a generous gift from Dr. Kenneth D. Philipson 
(University of California, Los Angeles, CA). All BHK cell lines were grown on plastic 
dishes in a mix of Dulbecco’s modified Eagle’s medium and Ham’s F-12 medium 
(1:1) (Life Technologies, San Giuliano Milanese, Italy) supplemented with 5% fetal 
bovine serum, 100 U/ml penicillin, and 100 mg/ml streptomycin (Sigma-Aldrich, St. 
Louis, MO). Cells were cultured in a humidified 5% CO2 atmosphere, and the culture 
medium was changed every 2 days. For microfluorimetric and electrophysiologic 
studies, cells were seeded on glass coverslips (Thermo Fisher Scientific, Springfield, 
NJ) coated with poly-L-lysine (30 mg/ml) (Sigma-Aldrich) and used at least 12h after 
seeding.  
Human embryonic kidney-293 (HEK293) cells were cultured in DMEM–Dulbecco's 
Modified Eagle Medium (Gibco) containing 10% fetal bovine serum, penicillin (50 
U/ml) and streptomycin (50 μg/ml), 2 mM Glutamine in a humidified atmosphere at 
37°C with 5% CO2. HEK293 cells endogenously express ASIC1a channels 
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(Gunthorpe et al., 2001). For electrophysiological experiments, cells were seeded on 
glass coverslips (Glaswarenfabrik Karl Hecht KG, Sondheim, Germany) coated with 
poly-L-lysine (50 µg/mL) and used after 24-72 hours in culture (Sigma-Aldrich, St. 
Louis, MO) to assess the effects of Compound 2 on ASIC1a currents. 
 
3.6 [Ca2+]i MEASUREMENT 
[Ca2+]i was measured by single-cell computer-assisted video imaging (Secondo et 
al., 2007). Briefly, BHK cells, grown on glass coverslips, were loaded with 6 mM 
Fura-2 acetoxymethyl ester (Fura-2 AM) for 30 minutes at 37°C in normal Krebs 
solution containing the following (in mM): 5.5 KCl, 160 NaCl, 1.2 MgCl2, 1.5 CaCl2, 
10 glucose, and 10 Hepes-NaOH (pH 7.4). At the end of the Fura-2 AM loading 
period, the coverslips were placed into a perfusion chamber (Medical Systems, 
Greenvale, NY) mounted onto the stage of an inverted Zeiss Axiovert 200 
microscope (Carl Zeiss, Oberkochen, Germany) equipped with a FLUAR 40X oil 
objective lens. The experiments were carried out with a digital imaging system 
composed of MicroMax 512BFT cooled CCD camera (Princeton Instruments, 
Trenton, NJ), LAMBDA 10-2 filter wheeler (Sutter Instruments, Novato, CA), and 
Meta-Morph/MetaFluor Imaging System software (Universal Imaging, West Chester, 
PA). After loading, cells were alternatively illuminated at wavelengths of 340 nm and 
380 nm by a xenon lamp. The emitted light was passed through a 512-nm barrier 
filter. Fura-2 fluorescence intensity was measured every 3 seconds. Forty to sixty-five 
individual cells were selected and monitored simultaneously from each coverslip. All 
the results are presented as cytosolic Ca2+ concentration. Since KD for Fura-2 was 
assumed to be 224 nm, the equation of Grynkiewicz (Grynkiewicz et al., 1985) was 
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used for calibration. NCX activity was evaluated as Ca2+ uptake through the reverse 
mode by switching the normal Krebs medium to Na+-deficient NMDG+ medium 
named Na+-free (in mM): 5.5 KCl, 147 NMDG, 1.2 MgCl2, 1.5 CaCl2, 10 glucose, and 
10 Hepes-Trizma (pH 7.4), in the presence of thapsigargin, the irreversible and 
selective inhibitor of the sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) 
(Secondo et al., 2007). 
Compound 2 was incubated with cells for 30 minutes before NCX activity was 
studied. Each EC50 of Compound 2 was obtained by fitting the data with the 
equation a + b x exp(-x/t), where a is the maximal response, b is the basal response, 
x is the drug concentration, and t is the EC50.  
 
3.7 ELECTROPHYSIOLOGY 
NCX Currents. NCX currents (INCX) were recorded, by patch-clamp technique in 
whole-cell configuration (Secondo et al., 2007; Molinaro et al., 2013) in BHK cells 
stably transfected with NCX1 exposed either to Compound 2 or its vehicle. 
Currents were filtered at 5 kHz and digitized using a Digidata 1322A interface 
(Molecular Devices, Sunnyvale, CA). Data were acquired and analyzed using the 
pClamp software (version 9.0; Molecular Devices). In brief, INCX were recorded 
starting from a holding potential of -70 mV up to a short-step depolarization at +60 
mV (60 ms) (Secondo et al., 2009a). Then, a descending voltage ramp from +60 mV 
to -120 mV was applied. The current recorded in the descending portion of the ramp 
(from +60 mV to -120 mV) was used to plot the current-voltage (I-V) relation curve. 
The magnitudes of INCX were measured at the end of +60mV (reverse mode) and at 
the end of -120 mV (forward mode), respectively. To isolate INCX, the same cells of all 
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experimental groups were recorded first for total currents and then for currents in the 
presence of Ni2+ (5 mM), a selective blocker of INCX. Compound 2-induced INCX 
increase was calculated as follows: (INCX Compound 2/INCX control) x 100. 
External Ringer solution contained the following (in mM unless otherwise specified): 
126 NaCl, 1.2 NaHPO4, 2.4 KCl, 2.4 CaCl2, 1.2 MgCl2, 10 glucose, and 18 NaHCO3, 
20 TEA, 10 nM TTX, and 10 mM nimodipine (pH 7.4). The dialyzing pipette solution 
contained the following (in mM): 100 potassium gluconate, 10 TEA, 20 NaCl, 1 Mg-
ATP, 0.1 CaCl2, 2 MgCl2, 0.75 EGTA, and 10 Hepes, adjusted to pH 7.2 with CsOH. 
TEA (20 mM) and Cs were included to block delayed outward rectifier K+ 
components; nimodipine (10 mM) and TTX (50nM) were added to external solution to 
block L-type Ca2+ channels and TTX sensitive Na+ channels, respectively. The 
quantifications of INCX were normalized for membrane capacitance and expressed as 
a percentage of controls as previously reported (Molinaro et al., 2008a; Molinaro et 
al., 2011), whereas the representative traces of INCX are expressed as picoamps per 
millivolt (pA/mV). 
Asic Currents. ASIC1a currents were measured on HEK293 by means of the patch-
clamp technique in the whole-cell configuration. Electrophysiological recordings were 
carried out at room temperature (20–24°C), using an Axopatch 200B amplifier 
controlled using the pClamp 10 software (Axon Instruments, Union City, CA, USA). 
The holding potential was -70 mV, traces were filtered at 5kHz and currents were 
digitized using a Digidata 1322A interface (Axon Instruments, Union City, CA, USA). 
The extracellular solutions contained (in mM) 140 NaCl, 5 KCl, 2 CaCl2, 2 MgCl2, 10 
HEPES, pH was adjusted to 7.4 using NaOH or HCl. For solution with pH 6.0, glycine 
10 mM and MES instead of HEPES were used for more reliable pH buffering. 
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Pipettes had a resistance of 2–4 MΩ when filled with the intracellular solution, which 
contained (in mM): 30 NaCl, 120 KCl, 2 MgCl2, 10 HEPES with or without EGTA, pH 
was adjusted to 7.3 using NaOH or HCl. The ASIC1a channel was activated by 
shifting the pH of the external solution from pH 7.4 to pH 6.0. Fast extracellular 
solution exchange was performed using a commercially available automated fast 
solution exchange system (Warner Instruments SF-77B). In particular, a rapid 
reduction of extracellular pH from 7.4 to pH 6.0 (10 seconds) evoked large transient 
inward currents. Between two-three stimulation cells were kept in a bath solution (pH 
7.4) for at least 40 seconds. After that, Compound 2 was pre-applied in extracellular 
solution pH 7.4 for 40 seconds and co-applied in extracellular solution pH 6.0 for 10 
seconds (approximately 50 seconds between pH stimulations).  
 
3.8 DETERMINATION OF MITOCHONDRIAL ACTIVITY 
Mitochondrial dysfunction was evaluated with the MTT method (Molinaro et al., 
2013). In brief, after the experimental procedures, BHK cells were washed with 
normal Krebs solution and incubated with a MTT solution (0.5 mg/ml in phosphate-
buffered saline). This yellow water-soluble tetrazolium salt is converted into a water-
insoluble purple formazan by the succinate dehydrogenase system of the active 
mitochondria. Therefore, the amount of formazan produced is proportional to the 
number of cells with mitochondria that are still alive. After 1h of incubation at 37°C, 
cells were dissolved in 1 ml of DMSO, in which the rate of MTT reduction was 
measured by a spectrophotometer at a wavelength of 540 nm. Data are expressed 
as percentage of mitochondrial dysfunction versus sham-treated cultures. 
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3.9 IMMUNOHISTOCHEMISTRY AND IMAGE ANALYSIS 
Immunostaining and confocal immunofluorescence procedures were performed as 
previously described (Anzilotti et al., 2015). Animals were anesthetized and 
transcardially perfused with saline solution containing 0.01 ml heparin, followed by 
4% paraformaldehyde in 0.1 mol/l PBS saline solution. Brains were rapidly removed 
on ice and postfixed overnight at +4°C and cryoprotected in 30% sucrose in 0.1 M 
phosphate buffer (PB) with sodium azide 0.02% for 24 h at 4°C. Next, brains were 
sectioned frozen on a sliding cryostat at 40 μm thickness, in rostrum-caudal direction. 
Afterwards, free floating serial sections were incubated with PB Triton X 0.3% and 
blocking solution (0.5% milk, 10% FBS, 1% BSA) for 1 h and 30 min. The sections 
were incubated overnight at +4 °C with the following primary antibodies: mouse 
monoclonal anti-NeuN (Millipore, Milan, Italy), mouse monoclonal anti-NCX1 (Swant, 
Bellinzona, Switzerland), rabbit polyclonal anti-phospho-CREB S133 (Millipore, Cat 
#06-519), mouse monoclonal anti-phospho-CaMKII T286 (Abcam, ab32678). 
The sections were then incubated with the corresponding florescent-labeled 
secondary antibodies, Alexa 488/Alexa 594 conjugated antimouse/antirabbit IgGs 
(Molecular Probes, Invitrogen S.R.L., Milan, Italy). Nuclei were counterstained with 
Hoechst (Sigma-Aldrich, Milan, Italy). Images were observed using a Zeiss LSM700 
META/laser scanning confocal microscope (Zeiss, Oberkochen, Germany). Single 
images were taken with an optical thickness of 0.7 m and a resolution of 1024 × 1024. 
In double-labeled sections, the pattern of immune reactivity for both antigens was 
identical to that seen in single-stained material. Control double-immunofluorescence 
staining entailed the replacement of the primary antisera with normal serum (data not 
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shown). To minimize a possible cross-reactivity between IgGs in double 
immunolabeling experiments, the full complement of secondary antibodies was 
maintained but the primary antisera were replaced with normal serum or only one 
primary antibody was applied (data not shown). In addition, the secondary antibodies 
were highly preadsorbed to the IgGs of numerous species. Tissue labeling without 
primary antibodies was also tested to exclude autofluorescence. No specific staining 
was observed under these control conditions, thus confirming the specificity of the 
immunosignals. 
To obtain an indirect measure of the amount of pCaMKII_T286, NCX1, and 
pCREB_S133 in neurons, image analysis of NeuN was performed by NIH image 
software by measuring the intensity of fluorescent NCX1, pCaMKII_T286 and 
pCREB_S133 immunolabeling in 60 NeuN positive neurons for each group. The 
intensity of NCX1 CaMKII_T286 and pCREB_S133 immunoreactivity was expressed 
in arbitrary units (Anzilotti et al., 2018). 
 
3.10 BEHAVIORAL STUDIES AND HORMONAL MEASUREMENTS 
At the age between 2-3 months, mice were behaviorally tested. Experiments were 
performed during the light phase between 11:00 a.m. and 3:00 p.m. During 
behavioral tests, animal movements were recorded by 2 cameras (resolution 
640x480 pixels) and analyzed by a dedicated software operating in video tracking 
mode (Anymaze) and manually by an experimental researcher. The system tracked 
the animal's head as well as its centre of gravity and tail. The results therefore 
included measures specific to the position of the animal and movements. The animal 
was considered to be immobile if it doesn't change location and at least 65% of its 
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body remains static for a period of 2000ms or more. The system detected periods 
when the animal is freezing for at least 250ms. Experiment's treatment groups were 
coded in blind with the experimental researcher involved in the score definition. 
For hormone assay, mice were sacrificed by CO2 and blood was collected from heart 
in ice-cooled centrifugal tubes. Serum corticosterone levels were measured in serum 
by Elisa (VetforLab, Pozzuoli, Italy) at 6:00 a.m., 12:00 p.m., 6:00 p.m. and 12:00 
a.m. under non-stressful conditions, or approximately 60m or 24h after foot-shock. 
Serum corticosterone levels at 12:00 p.m. were used as control group for 1h and 24h 
after foot-shock groups. 
 
3.11 OPEN-FIELD EXPLORATION AND NOVEL OBJECT RECOGNITION 
MEMORY TASK  
Open field and novel object recognition task were performed as previously described 
(Molinaro et al., 2011). Briefly, the open field apparatus (50x50 cm, 40 cm high) was 
placed in a homogenously lit experimental room with several large-scale 
environmental visual cues. Ninety animals (13 NCX1.4over, 12 NCX1.4+/+, 17 NCX1ko, 
19 NCX1+/+, 14 compound 2-treated C57BL/6, 15 vehicle-treated C57BL/6) were 
individually placed in the apparatus and were allowed to explore it for 5 min. Several 
parameters, including total traveled distance, were measured by using an automated 
tracking software (Anymaze). The time spent by animals in three concentric areas 
was automatically measured as an index of anxious behavior (Kassed and 
Herkenham, 2004; Kazlauckas et al., 2005). The same apparatus was also used for 
the object recognition task. Compound 2, or vehicle, was administered once 30m 
before the begin of the test by i.p. injection.  
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Novel object recognition memory task was performed 30m after open field test, thus 
no additional drug administration was provided for this test neither in training, 1h nor 
24h session. During the training trial, two objects were placed in the box and animals 
were allowed to explore them for 5 min. A mouse was considered to be exploring the 
object when its head was facing the object within 27mm of distance. Following 
retention intervals (1h and 24h), animals were placed back to the box with two 
objects in the same locations, but one of the familiar objects was replaced by a novel 
object and then were allowed to explore the two objects for 5 min. The preference 
percentage, ratios of the amount of time spent exploring any one of two objects or 
the novel one over the total time spent exploring both objects, were used to assess 
the recognition memory. 
 
3.12 ROTAROD 
Motor coordination and balance were assessed using a five-station mouse rotarod 
apparatus (Ugo Basile; Milan, Italy). In each station, the rod was 6 cm in length and 3 
cm in diameter. Mice were trained to maintain balance at increasing speed from 4 to 
14 rpm for three consecutive trials over 60 s. The test sessions were conducted by 
three trials of rotarod over 60 s under the same conditions of the training session. 
The maximum latency of 60 s was assigned to the mice that did not fall at all 
(Giampà et al., 2010). Compound 2, or vehicle, was administered by i.p. 30m before 
the test session. Data were expressed as mean of the three trials in the test session. 
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3.13 ELEVATED ZERO MAZE AND DARK/LIGHT BOX 
The elevated-O-maze is a modification of the plus-maze and displays the advantage 
of lacking the ambiguous central area of the elevated plus-maze. Zero maze 
consisted of a circular path with an outer diameter of 122 cm and with a catwalk of 
10 cm wide. With regard to mice’s natural aversion towards elevated and open 
spaces (Shepherd et al., 1994; Kulkarni et al., 2007) the catwalk was positioned at a 
height of 40 cm and divided into four subsections: two “closed” (wall height: 30 cm) 
and two “open” quadrants. Testing took place approximately at 12:00 a.m. with equal 
lighting conditions that provided a maze surface free of distracting shadows. 
Compound 2, or vehicle, was administered by i.p. 30m before the test. After at least 
30m of habituation to the experiment room, each mouse was placed alternately into 
the center of one of the open quadrants and video-recorded for 5m. The time spent in 
the open quadrants was expressed as percentage of the respective wild-type or 
vehicle group.  
Dark/light box apparatus consisted of two transparent polyvinylchloride boxes (22x38 
cm, 15cm height). One of the boxes was covered and darkened, whereas the other 
box was well lighted. The two boxes contained some dust-free sawdust bedding and 
are linked by a window (10 cm wide, 6.5 cm height). The subjects were individually 
tested from 11 a.m. to 3 p.m. in two sessions: before (naïve) and after (post-shock) a 
single foot-shock. Mice were placed in the lit box at the beginning of the test. The 
amount of time spent in the lit box and the number of transitions across the two 
boxes were automatically and manually recorded. A mouse whose four paws were in 
the new area was considered having changed box. During the video-recording, the 
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experimenters were not present in the room. Analysis was performed post-hoc on 
videorecording movie.  
3.14 BARNES CIRCULAR MAZE TASK 
Apparatus. The behavioral apparatus used in this experiment consisted of a white 
circular platform (1.22 m diameter) elevated 80 cm above the floor, with 36 equally 
spaced holes (each 5 cm diameter) around the periphery (5 cm from the perimeter). 
Only one hole led to a dark escape box (5 cm x 5 cm x 11 cm) that was fixed in 
relation to the distal environmental cues and contained some dust-free sawdust 
bedding. The platform surface was brightly illuminated from above to motivate to 
escape in the dark box (Bach et al., 1995; Seeger et al., 2004). 
Procedure. Mice were gently picked up from the tail and placed in the middle of the 
platform. The direction faced by the animals at the start position was random and 
changed from trial to trial. After 5 min, if the mice did not find the goal they were 
gently directed toward the correct hole and allowed to descend into the escape box 
where they were left for 1 min (Bach et al., 1995; Seeger et al., 2004). The following 
5 test trials (one trial per day) were performed under same conditions. Each trial 
ended when the mouse entered the goal escape box or after a maximum time of 5 
min. The amount of time it took the mice to enter the escape hole (escape latency) 
was recorded (Bach et al., 1995; Seeger et al., 2004). 
 
3.15 TRACE FEAR CONDITIONING 
The trace fear conditioning procedure is a modified form of tone (delay) fear 
conditioning because it demands a “trace interval” between the unconditioned 
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stimulus (US) and conditioned stimulus (CS). Unlike delay tone conditioning, the 
acquisition of trace fear conditioning is sensitive to hippocampal lesions (McEchron 
et al., 1998; Desmedt et al., 2003; Bangasser et al., 2006) and to genetic 
modifications of the hippocampus (Huerta et al., 2000; D'Adamo et al., 2002). In this 
test a fear-conditioning shock chamber (17x17 cm, 25 cm height) containing a 
stainless-steel rod floor (2.5 mm diameter, spaced 1 cm apart, Ugo Basile Inc.) and a 
digital camera to monitor animal movements were used in a soundproof box (Ugo 
Basile Inc.). The apparatus for on-line tracking and stimulus/shock delivery was 
controlled using anymaze software v5.31. 
Briefly, for the conditioning (Lu et al., 1997; Jeon et al., 2003), mice were first placed 
in the fear-conditioning apparatus chamber for 3 min (habituation phase), and, then, 
a 15 s acoustic CS (1000 Hz, 80 dB) was delivered. The tone intensity and 
frequency, previously tested in C57BL/6 mice, did not evoke freezing before 
conditioning although short orienting reactions showed their ability to perceive the 
sound. After 15 s from the end of the acoustic stimulus, a 0.5mA shock (0.8 s 
duration) of unconditioned stimulus was applied to the floor grid. This protocol was 
performed one time per animal. Compound 2, or vehicle, was administered 30m 
before the habituation phase. 
Context test of trace fear conditioning was measured 30m after the conditioning 
procedure. Animals were tested for their context freezing response and afterward for 
their response to the tone in a different context. 
Context freezing response was measured placing the animals for 5m in the same 
apparatus used for conditioning in absence of electrical or acoustical stimuli. 
Behavior was recorded with a digital camera and analyzed by software (anymaze) for 
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the freezing behavior, defined as complete absence of somatic movements except 
for respiratory movements. 
To assess the tone test in trace fear conditioning, the animals were placed in a 
different context (novel chamber, odor, floor, and visual cues) 30m after the context 
test, and their behavior was monitored for 6 min. All experimental groups were 
observed for 3m before the tone (pre-CS) and 3m (CS) during the tone in the new 
context. Fear response was quantified by measuring the duration of freezing 
behavior. Freezing behavior was defined as a total lack of movement, apart from 
respiration.  
 
3.16 STATISTICAL ANALYSIS 
Values are expressed as means ±S.E.M. Statistical analysis was performed with 
paired or unpaired Student’s t test, Kruskal-Wallis one or two Way ANOVA followed 
by Dunn’s test with all pairwise multiple comparison procedures or Student-Newman-
Keuls post-hoc test. Statistical significance was accepted at the 95% confidence level 
(p < 0.05).  
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4. RESULTS 
4.1 NEWLY SYNTHESIZED COMPOUNDS MODULATING NCX ACTIVITY 
Twenty newly compounds have been synthesized by different modifications on the 
chemical backbone of neurounina-1 (7-nitro-5-phenyl-1-(pyrrolidin-1-ylmethyl)-1H-
benzo[e][1,4]diazepin-2(3H)-one) (Figure 1). The benzodiazepinonic derivatives are 
obtained by the addition of cyclic amine via an acetic spacer (compounds I-VIII) or by 
an ethylic spacer (in compound 4 and compounds IX-XVI) to the position 1 of 
neurounina-1 (Figure 1). Moreover, compounds 2 and 3 were generated by the 
addition of a chloride residue in position 2 and 7, respectively (Figure 1). 
The effects of newly synthesized compounds on all three NCX isoforms were 
evaluated with 45Ca2+ radiotracer, fura-2-monitored Ca2+ increase and patch clamp in 
whole cell configuration methods ( Figure 2) on BHK cells singly transfected with 
NCX1, NCX2 or NCX3. Among the twenty new compounds, five of them were 
selected: compounds 2 and 3 that are able to increase NCX1 activity ( Figure 2A); 
compounds II and IX that are inhibitors of NCX2 activity ( Figure 2B); and compound 
III for its effect as activator on NCX3 ( Figure 2C). The concentration effect-curves 
evaluated on each NCX isoform revealed that compounds 2 and 3 show an EC50 of 
1.4 nM and 1.3 nM on NCX1 (Figure 3), respectively. Compounds IX inhibited NCX2 
activity with an EC50 of 2,9 nM and Compound II modulated both NCX1 and NCX2 
activity (Figure 4). Compound III increases NCX3 and NCX1 activity but no EC50 was 
calculated (Figure 5). 
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Figure 1. Chemical structure of twenty derivatives of neurounina-1.  
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 Figure 2. Effects of newly synthesized compounds on the three NCX isoforms. 
(A) and (C) Effects of new compounds on NCX1 or NCX3 activity evaluated with single cell 
Fura-2 monitored Ca2+ technique. 
(B)  Effects of new compounds on NCX2 activity evaluated with 45Ca2+ radiotracer assay. 
Arrows show selected compound for in vivo experiments. 
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Figure 3. Dose-effect curves of compounds 2 and 3. 
Concentration-response curves of compound 2 (A) and compound 3 (B) on Na+-
dependent 45Ca2+ efflux in BHK cells expressing NCX1, NCX2 or NCX3. *, p < 0.05 vs 
respective NCX2 and NCX3, two-way ANOVA followed by Newman-Keuls’ test. 
Compound 2, F(2,144) = 20.34, p<0.0001; Compound 3, F (2, 114) = 7.224, p=0.0011. 
* 
* 
* * 
* 
* 
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Figure 4. Dose-effect curves of compounds II and IX. 
Concentration-response curves of compound II (A) or compound IX (B) on Na+-
dependent 45Ca2+ efflux in BHK cells expressing NCX1, NCX2 or NCX3. *, p < 0.05 vs 
respective NCX2 and NCX3; §, p < 0.05 vs respective NCX1 and NCX3. Two-way 
ANOVA followed by Newman-Keuls’ test. Compound II, F(2,127) = 41.08, p<0.0001; 
Compound IX, F (2, 62) = 8.027, p=0.0008. 
* * 
* 
§ 
§ 
 
§ 
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Figure 5 Dose-effect curves of compound III. 
Concentration-response curves of compound III on Na+-dependent 45Ca2+ efflux in BHK 
cells expressing NCX1, NCX2 or NCX3.  
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4.2 COMPOUNDS 2 AND IX AMELIORATE LEARNING AND MEMORY 
PERFOMANCE IN NOVEL OBJECT RECOGNITION TEST 
Ten nM and 10 µM of each selected compound did not decrease mitochondrial 
activity on BHK cells as measured with MTT assay (Figure 6A). Moreover, a single 
i.p. injection of 32 µg/kg of compound 2, 3, II, III or IX did not cause body weight loss 
after one and two weeks (Figure 6B), signs of suffering, and evident toxic effects on 
several organs such as liver, kidney, pancreas and gut. Furthermore, the total 
distance travelled and the total time mobile in open field test (  Figure 7 A and B) and 
the latency to fall in rotarod test (Figure 9) did not reveal impairment of locomotor 
activity for mice treated with each compound. Moreover, compounds did not affect 
the number of entries in open zone and the percentage of time spent by mice in open 
zone of zero maze test (Figure 8 A and B). 
In novel object recognition test each mouse group were equally motivated to explore 
the two objects during the training phase (Figure 10, Figure 11, Figure 12). One hour 
and 24 hours later, when one object was replaced with a new one, mice treated with 
compound 2 (Figure 10A) and compound IX (Figure 11B) spent more time exploring 
the novel object, as compared with vehicle-treated mice. Compound 3-treated mice 
ameliorated learning and memory performance only 24h after the training session 
(Figure 10B). On the other hand, mice treated with compound II (Figure 11A) and III 
(Figure 12) displayed the same performance of exploration of vehicle treated mice. 
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Figure 6. In vitro and in vivo toxicity evaluated for the five selected compounds. 
(A) Mitochondrial activity of BHK cells incubated with vehicle, 10 nM or 10 µM of compounds 
2, 3, II, III and IX. ANOVA followed by Tukey’s post-hoc test. 
(B) Mouse weight measured 7 days or 14 days after a single i.p. injection of vehicle or 32 
µg/kg of compounds 2, 3, II, III and IX. ANOVA followed by Tukey’s post-hoc test 
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  Figure 7. Locomotor activity examined in the open field test. 
(A) Quantification of total distance travelled in open field test in mice treated with vehicle 
(20.84m ± 0.86, n=15), compound 2 (21.65m ± 1.63, n=14), compound 3 (20.10m ± 1.38, 
n=15), compound II (18.26m ± 1.22, n=15) compound III (19.67m ± 1.05, n=15), 
compound IX (20.54m ± 1.05, n=15). ANOVA followed by Tukey’s post-hoc test. 
(B) Quantification of total time spent moving in open field test expressed in seconds in mice 
treated with vehicle (178.03s ± 5.68, n=15), compound 2 (182.44s ± 7.9, n=14), 
compound 3 (174.01s ± 7.66, n=15), compound II (167.01s ± 8.6, n=15) compound III 
(172.00s ± 4.79, n=15), compound IX (179.33s ± 6.06, n=15). ANOVA followed by 
Tukey’s post-hoc test. 
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Figure 8. Anxiety levels examined in zero maze test. 
(A)  Results of number of entries in the open zone of zero maze apparatus in mice treated 
with vehicle (19.33 ± 0.81 n=15), compound 2 (22.57 ± 0.75 n=14), compound 3 (19.93 ± 
1.13 n=15), compound II (20.93 ± 0.75 n=15) compound III (19.53 ± 1.42 n=15), 
compound IX (20.00 ± 1.02 n=15). ANOVA followed by Tukey’s post-hoc test 
(B) Quantification of total time spend in the open zone of zero maze apparatus expressed as 
percentage of vehicle-treated control group vehicle (29.12% ± 1.89 n=15), compound 2 
(29.91% ± 1.85 n=14), compound 3 (29.70% ± 1.66 n=15), compound II (28.45% ± 1.52 
n=15) compound III (29.61% ± 1.88 n=15), compound IX (28.08% ± 1.60 n=15). ANOVA 
followed by Tukey’s post-hoc test. 
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Figure 9. Evaluation of locomotor activity with rotarod test. 
Average of time latency to fall in wild-type mice treated with vehicle (27s ± 2.8 n=15), 
compound 2 (26s ± 2.4 n=14), compound 3 (24s ± 2.5 n=14), compound II (27s ± 2.8 n=15), 
compound III (24s ± 2.9 n=15) or compound IX (22 ± 2.1 n=15) in rotarod task. ANOVA 
followed by Tukey’s post-hoc test.  
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Figure 10. Novel object recognition test of mice treated with compound 2 or 3. 
(A) Mean exploratory preference during training session and each retention time in vehicle-
treated (n=15) *p<0.05 vs training, ANOVA followed by Tukey’s post-hoc test. F(2,42) = 
6,30, p=0.004 on the left; and compound 2-treated (n=14) mice. ANOVA followed by 
Tukey’s post-hoc test. F(2,39) = 42,62, p<0.001 on the right. §, p<0.05 vs vehicle-treated 
group, Unpaired Student’s t test. 
(B) Mean exploratory preference during training session and each retention time in vehicle-
treated (n=15) *p<0.05 vs training, ANOVA followed by Tukey’s post-hoc test. F(2,42) = 
6,30, p=0.004 on the left; and compound 3-treated (n=15) mice*p<0.05 vs training, 
ANOVA followed by Tukey’s post-hoc test. F(2,42) = 48,19, p<0.001 on the right. §, 
p<0.05 vs vehicle-treated group, Unpaired Student’s t test. 
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Figure 11. Novel object recognition test of mice treated with compound II or IX. 
(A) Mean exploratory preference during training session and each retention time in vehicle-
treated (n=15) *p<0.05 vs training, ANOVA followed by Tukey’s post-hoc test. F(2,42) = 
6,30, p=0.004 on the left; and compound II-treated (n=14) mice*p<0.05 vs training, 
ANOVA followed by Tukey’s post-hoc test. F(2,42) = 19,08, p<0.001 on the right.  
(B) Mean exploratory preference during training session and each retention time in vehicle-
treated (n=15) *p<0.05 vs training, ANOVA followed by Tukey’s post-hoc test. F(2,42) = 
6,30, p=0.004 on the left; and compound IX-treated (n=15) mice*p<0.05 vs training, 
ANOVA followed by Tukey’s post-hoc test. F(2,42) = 82,44, p<0.004 on the right. §, 
p<0.05 vs vehicle-treated group. Unpaired Student’s t test. 
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Figure 12. Novel object recognition test of mice treated with compound III. 
Mean exploratory preference during training session and each retention time in vehicle-
treated (n=15) *p<0.05 vs training, ANOVA followed by Tukey’s post-hoc test. F(2,42) = 
6,30, p=0.004 on the left; and compound III-treated (n=14) mice*p<0.05 vs training, 
ANOVA followed by Tukey’s post-hoc test. F(2,42) = 29,25, p<0.001 on the right. 
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4.3 COMPOUNDS 2, II AND IX AMELIORATE SPATIAL MEMORY IN BARNES 
MAZE AND TRACE FEAR CONDITIONING TESTS 
The treatment with compounds 2, 3 II, III or IX did not ameliorate spatial learning 
during trial 1-5 of Barnes maze test (Figure 13, Figure 14, Figure 15). Indeed, 
experimental groups treated with compound 2 or III required more time to find the 
escape box as compared with vehicle-treated mice on the trial two (Figure 13A, 
Figure 15). On the other hand, during the memory recall phase (trial 6) the escape 
box was removed, and mice previously treated with compound 2, II or IX spent 
significantly more time in the probe zone, where before was located the escape box, 
as compared with vehicle-treated mice (Figure 16 B, Figure 17 E). The treatment with 
compound 2, or II, induced an increase of the number of entries in the probe zone 
(Figure 16 C, Figure 17 C), but only mice treated with compound 2 significantly 
increased the time spent in the correct quadrant, Q1 (Figure 16 A). However, mice 
treated with compound 3, or III, did not ameliorate spatial memory during the trial 6 of 
Barnes maze test (Figure 16 D-E, Figure 18 A-B). 
In the trace fear conditioning test compound 2-treated group increased fear response 
in the same environment where mice 30 minutes before received the foot-shock 
(context trial 30m) (Figure 19 A). Moreover, in the cue test, mice treated with 
compound II showed a significant increase freezing behavior in the new environment, 
when subjected to the acoustic stimulus (CS) 60 min training session (Figure 20 C). 
In addition, 24 h after the training session vehicle group did not recognize the CS 
whereas compounds 2, II and IX significantly increased freezing behavior when 
subjected to the CS in the new environment (Figure 21).  
 
48 
 
Figure 13. Learning phase of Barnes maze test in mice treated with compound 2 or 3. 
Results of time to find the escape box during learning phase (trial 1-5) of Barnes maze 
test in compound 2-treated (n=15) (A) compound 3-treated (n=14) (B) and vehicle-treated 
(n=14) C57BL/6 mice. *, p<0.05 vs trial 1, ANOVA followed by Dunn’s post-hoc test. 
Treatment F(5,79)=1.5548, p=0.183. 
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Figure 14. Barnes maze test (learning phase) of mice treated with compound II and IX. 
Results of time to find the escape box during learning phase (trial 1-5) of Barnes maze 
test in compound II-treated (n=15) (A), compound IX-treated (n=14) (B), and vehicle-
treated (n=14) C57BL/6 mice. *, p<0.05 vs trial 1, ANOVA followed by Dunn’s post-hoc 
test. Treatment F(5,79)=1.5548, p=0.183 
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Figure 15. Barnes maze test (learning phase) of mice treated with compound III.  
Results of time to find the escape box during learning phase (trial 1-5) of Barnes maze 
test in compound III-treated (n=15) and vehicle-treated (n=14) C57BL/6 mice. *, p<0.05 
vs trial 1, ANOVA followed by Dunn’s post-hoc test. Treatment F(5,79)=1.5548, p=0.183 
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Figure 16. Barnes maze test (learning phase) of mice treated with compound 2 or 3.  
(A and D) Quantification of time spend in Q1 during trial 6 by mice treated with vehicle 
(24.11% ± 1.73, n=14), compound 2 (31.77% ± 2.41, n=15) (A), or compound 3 
(21.66% ± 2.44, n=14) (D). Time is expressed as percentage of test duration. §, p<0.05 
vs vehicle treated mice, unpaired Student’s t test. 
(B and E) Quantification of time spent in the probe zone by mice treated with vehicle 
(11.61s ± 1.62, n=14), compound 2 (19.74s ± 2.39, n=15) (B), or compound 3 (14.07 ± 
2.11, n=14) (E) during trial 6, expressed as percentage of test duration. §, p<0.05 vs 
respective vehicle treated mice, unpaired Student’s t test. 
(C)  Results of the number of entries in the probe zone during trial 6 of Barnes maze test in 
vehicle (4.5 ± 0.7, n= 14) and compound 2 (8.27 ± 1.36, n=15) groups. Unpaired 
Student’s t test.  
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Figure 17. Barnes maze test (learning phase) of mice treated with compound II or IX.  
(A and D) Quantification of time spend in Q1 during trial 6 by mice treated with vehicle 
(24,11% ± 1.73, n=14), compound II (29.62% ± 2.43, n=15) (A) or compound IX (28.48% 
± 2.42, n=13) (D). Time is expressed as percentage of test duration.  
(B and E) Quantification of time spent in the probe zone by mice treated with vehicle (11.61s 
± 1.62, n=14), compound II (16.16 ± 1.42 n=15) (B) or compound IX (18.2s ± 2.78, n=13) 
(D) during trial 6, expressed as percentage of test duration. §, p<0.05 vs respective 
vehicle-treated mice, unpaired Student’s t test. 
(C and F)  Results of the number of entries in the probe zone by vehicle-treated (4.5 ± 0.7, 
n=14), compound II-treated (6.8 ± 0.63, n=15) (C) or compound IX-treated (6.46 ± 0.67, 
n=13) (F) mice during trial 6 of Barnes maze. Unpaired Student’s t test.  
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Figure 18. Barnes maze test (learning phase) of mice treated with compound III. 
(A) Quantification of time spend in Q1 during trial 6 by mice treated with vehicle (24.11% ± 
1.73 n=14) or compound III (26.27% ± 2.21 n=15). Time is expressed as percentage of 
test duration.  
(B)  Quantification of time spent in probe zone during trial 6 of Barnes maze by vehicle 
(11.61s ± 1.61 n=14) or compound III (13.06 ± 1.38 n=15) group. 
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Figure 19. Contextual fear conditioning for the three selected compounds. 
(A, C and E) Quantification of freezing time of vehicle (n=24), compound 2 (n=24) (A), 
compound II (n=15) (C), and compound IX (n=15) (E) measured in the same environment 
where 30 minutes before they received a foot-shock during the training phase. Freezing 
time is expressed as total seconds in freezing behavior. §, p<0.05 vs corresponding 
55 
 
segment of vehicle group, ANOVA followed by Dunn’s post-hoc test. Treatment F(5,103) 
= 1.0404, p=0.398; Segment of Test F(4,412)=7.4888, p<0.0001. 
(B, D and F)  Quantification of freezing time in the same environment where vehicle (n= 
24), compound 2 (n=24) (B), compound II (n=15) (D), and compound IX (n=15) (F) 
groups received the foot-shock 4 days before. Freezing time is expressed as total 
seconds in freezing behavior. Treatment F(5,83) = 1.9952, p=0.088; Segment of Test 
F(4,332)=31.2681, p<0.0001. 
 
  
56 
 
 
Figure 20. Cue trial (1h) of trace fear conditioning test for the three selected compounds. 
(A)  Quantification of freezing behavior in a new environment, 1h after the training, under 
basal conditions (empty histogram) and in presence of the CS (full histogram) for mice 
treated with vehicle (13.81s ± 2.22, 34.37s ± 4.63, n=25). *, p<0.05 vs vehicle group “no 
sound”, unpaired Student’s t test. 
(B) Quantification of freezing behavior in a new environment, 1h after the training, under 
basal conditions (empty histogram) and in presence of the CS (full histogram) for mice 
treated with compound 2 (18.61s ± 3.27, 52.04s ± 7.6 n= 24). *, p<0.05 vs “no sound” 
group, unpaired Student’s t test.  
(C) Quantification of freezing behavior in a new environment, 1h after the training, under 
basal conditions (empty histogram) and in presence of the CS (full histogram) for mice 
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treated with compound II (20.76s ± 4.87, 61.59s ± 8.94 n=15). *, p<0.05 vs “no sound” 
group, unpaired Student’s t test. §, p<0.05 vs “sound” group, unpaired Student’s t test. 
(D) Quantification of freezing behavior in a new environment, 1h after the training, under 
basal conditions (empty histogram) and in presence of the CS (full histogram) for mice 
treated with compound IX (22.81s ± 5.41, 56.84 ± 9.67, n=15). *, p<0.05 vs “no sound” 
group, unpaired Student’s t test.  
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Figure 21. Cue trial (24h) of trace fear conditioning test for the three selected compounds. 
(A)  Quantification of freezing behavior in a new environment, 24h after the training, under 
basal conditions (empty histogram) and in presence of the CS (full histogram) for mice 
treated with vehicle (31.68s ± 4.53, 39.47s ± 5.07 n=20).  
(B) Quantification of freezing behavior in a new environment, 1h after the training, under 
basal conditions (empty histogram) and in presence of the CS (full histogram) for mice 
treated with compound 2 (50.33s ± 5.31, 63.54s ± 6.97 n=19). §, p<0.05 vs vehicle 
“sound” group, unpaired Student’s t test; #, p<0.05 vs vehicle “no sound” group, unpaired 
Student’s t test. 
(C) Quantification of freezing behavior in a new environment, 1h after the training, under 
basal conditions (empty histogram) and in presence of the CS (full histogram) for mice 
treated with compound II (39.07s ± 8.48, 73.89s ± 11.69 n=15). *, p<0.05 vs “no sound” 
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control group, unpaired Student’s t test; §, p<0.05 vs vehicle “sound” group, unpaired 
Student’s t test. 
(D) Quantification of freezing behavior in a new environment, 1h after the training, under 
basal conditions (empty histogram) and in presence of the CS (full histogram) for mice 
treated with compound IX (53.43s ± 7.73, 59.18s ± 7.42, n= 15). §, p<0.05 vs vehicle 
“sound” group, unpaired Student’s t test.  
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4.4 COMPOUND 2 SELECTIVELY INCREASES NCX1 ACTIVITY 
Analysis of Na+ dependent-45Ca2+ efflux in BHK cells singly transfected with each 
NCX isoform showed that 10 nM of compound 2 selectively increases NCX1 activity 
(Figure 22). Moreover, concentration-effect curve performed with fura-2 techniques 
displayed an EC50 in the low nanomolar range (1.4 nM) for compound 2 (Figure 
23B). The stimulatory effect of compound 2 in NCX1 activity was also confirmed by 
patch clamp in whole cell configuration technique in both forward and reverse modes 
of operation (Figure 24 A and B). Compound 2 till the concentration of 10 μM did not 
affect ASIC1a currents (Figure 25), a channel involved in the control of anxiety and 
spatial memory and that is also regulated by several drugs targeting NCX1. 
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Figure 22. Compound 2 selectively increases NCX1 activity. 
Quantification of NCX1, NCX2 and NCX3 activity measured trough Na+-dependent 45Ca2+ 
efflux in BHK cells treated with 10 nM of compound 2. F(3,12) = 16,53, *p<0.001; 
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Figure 23. Concentration-response curve of compound 2 on NCX1 activity measured by 
Fura-2 technique. 
(A) Superimposed traces representing the effect of compound 2 or vehicle on Na+-free-
induced [Ca2+]i increase in BHK-NCX1 cells. 
(B) Quantification of the effect of compound 2 on NCX1 activity measured by single-cell 
Fura-2 AM microfluorimetry in BHK-NCX1 cells (n=60 cells for each group). Data are 
calculated as ∆% of plateau/basal [Ca2+]i values after Na+ free addition. §, p<0.05 vs 
vehicle and 1 nM, §§, p<0.05 vs all groups, ANOVA followed by Student-Newman-Keuls 
post-hoc test. 
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Figure 24. Effect of compound 2 on NCX1 activity in reverse and forward modes of operation 
measured by patch-clamp technique in whole cell configuration. 
(A)  Superimposed traces on INCX1 currents recorded from BHK-NCX1 cells treated with 
vehicle or 10 nM of compound 2. 
(B) Quantification of the effects of 10 nM compound 2 on NCX1 currents in reverse and 
forward modes of operation. §, p<0.05 vs respective vehicle control group, unpaired 
Student’s t test.  
64 
 
 
Figure 25. Effects of compound 2 on ASIC1a currents measured by patch-clamp in whole 
cell technique. 
(A) Representative traces of the effects of compound 2, or vehicle, on ASIC1a currents 
activated by shifting the pH of external solution from pH 7.4 to 6.0.  
(B) Quantification of ASIC1a currents in presence of vehicle, 10 nM or 10 µM of compound 2 
expressed as percentage of vehicle group.  
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4.5 COMPOUND 2 INCREASES ANXIETY RESPONSE  
Corticosterone levels measured in peripheral blood of C57BL/6 mice 6:00 a.m., 12:00 
p.m., 18:00 p.m. and 12:00 a.m. revealed a regular circadian rhythm (Figure 26 A).  
Compound 2-treated mice spent less time in the external zone, more time in the 
intermediate zone (Figure 26 B) and increased their total time freezing as compared 
with vehicle-treated mice (Figure 26 C), in the open field test. However, here were no 
differences of the time spent in light zone for both experimental groups in the 
dark/light box test under basal conditions. Furthermore, compound 2-treated mice 
significantly reduced the time of residence in the light zone as compared with vehicle-
treated mice after a slightly foot-shock (Figure 27 A). In addition, both mouse groups 
increased plasma corticosterone levels 1h after the foot-shock, whereas compound 
2-treated group showed significant lower levels as compared with vehicle group 24h 
later (Figure 27 B). 
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Figure 26. Effects of compound 2 on anxiety levels under basal conditions. 
(A)  Concentration of corticosterone measured in peripheral blood of C57BL/6 or C57BL/6 
treated with compound 2 at different time points. 
(B) Quantification of total time spent in external, intermediate or inner zones of open field 
arena by vehicle-treated (n=15) or compound 2-treated (n=14) mice. Time is expressed 
in seconds. §, p<0.05 vs vehicle group, unpaired Student’s t test. 
(C) Quantification of total time spent in freezing behavior during the open field test expressed 
in seconds. §, p<0.05 vs vehicle-treated mice, unpaired Student’s t test. 
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Figure 27. Effects of compound 2 on anxiety levels after foot-shock. 
(A) Quantification of total time spent in the light box during pre-shock session (vehicle=14; 
compound 2=15) and during post-shock session (vehicle=10; compound 2=10) 
expressed in seconds. §, p<0.05 vs vehicle treated group, unpaired Student’s t test. 
(B) Concentration of corticosterone measured in peripheral blood of C57BL/6s mice treated 
with vehicle (n=5) or compound 2 (n=5) under control conditions, corresponding to the 
12:00 p.m. measurement, and after 1h or 24 hours after the foot-shock. . *, p<0.05 vs 
respective Vehicle-treated group, Unpaired Student’s t test §, p<0.05 vs respective control 
group, Unpaired Student’s t test.  
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4.6 COMPOUND 2-TREATED MICE INCREASE PHOSPHORYLATED CaMKII 
LEVELS IN THEIR HIPPOCAMPUS 
pCaMKII_T286 and pCREB were evaluated in cortex and hippocampus of mice 
treated with compound 2 or vehicle by western blot assay. In particular, 
pCaMKII_T286 levels significantly increased in hippocampus of compound 2-treated 
mice (Figure 28A) and no change in the total amount of pCREB was detected in the 
same brain region (Figure 28B). Moreover, western blots revealed no change in 
pCaMKII_T286 or pCREB total amount in cortex of treated mice (Figure 28 A and B). 
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Figure 28. Quantification of phosphorylated CaMKII and CREB in hippocampus and cortex 
of mice treated with compound 2 or vehicle. 
(A) Quantification of pCaMKII_T286 and pCAMKII_T305 in hippocampus (on the left) and in 
cortex (on the right) of mice treated with compound 2, or vehicle, normalized for tubulin 
and expressed as percentage of vehicle-treated group. §, p<0.05 vs vehicle-treated 
mouse group, unpaired Student’s t test. 
(B) Quantification of pCREB in hippocampus (on the top) and in cortex (on the bottom) of 
mice treated with compound 2, or vehicle, normalized for total CREB and expressed as 
percentage of vehicle-treated group.  
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4.7 KNOCK-OUT OR OVEREXPRESSION OF NCX1 IN NEURONS OF 
HIPPOCAMPUS, AMYGDALA AND CORTEX AFFECT THE PHOSPHORYLATION 
OF CREB AND CaMKII  
The immunofluorescence analysis did not show any significant morphological 
abnormalities in the hippocampus, striatum, cortex and amygdala of NCX1ko and 
NCX1.4over mice as showed by NeuN neuronal marker (Figure 29-Figure 31). In 
addition, the quantification of number of neurons revealed no differences between 
experimental and respective control groups (Molinaro et al., 2016). 
NCX1 immunosignal was reduced in cortex, amygdala and in both dorsal and ventral 
hippocampal subregions of NCX1ko mice and increased in the same regions of 
NCX1.4over mice (Figure 29-Figure 31). In addition, phosphorylated CREB at Ser133 
(pCREB) and the active form of phosphorylated CaMKII at Thr286 (pCaMKII_T286), 
were significantly reduced in hippocampus (Figure 35, Figure 36, Figure 39, Figure 
40), amygdala (Figure 34, Figure 38) and cortex (Figure 33, Figure 37) of NCX1ko 
and increased in same brain regions of NCX1.4over mice. Accordingly, western blot 
analysis confirmed that pCREB was reduced in hippocampus (Figure 41 A) and 
cortex (Figure 42A) of NCX1ko and was increased in same brain regions of 
NCX1.4over. Similarly, pCaMKII_T286 was reduced in the hippocampus of NCX1ko 
and increased in same brain region of NCX1.4over (Figure 41 B). On the other hand, 
no variation of pCaMKII_T286 was detected in cortex of the two genetic modified 
mice (Figure 42 B). In addition, the inactive phosphorylated form of CaMKII 
(pCaMKII_T305) was reduced in the hippocampus of NCX1ko (Figure 41 B) and in 
the cortex of NCX1.4over mice (Figure 42 B).  
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Figure 29. NCX1 immunosignal in the cortex of NCX1ko and NCX1.4over mice. 
Immunofluorescence images showing cortex of NCX1.4over (Over), NCX1.4+/+ (WT), NCX1ko 
(KO) and NCX1+/+ (WT) mice. Overview pictures and high-magnification photomicrographs 
showing the colocalization of NeuN (green: a, b, c, d) and NCX1 (red: e, f, g, h) in amygdala. 
Scale bars, 200 μm or 25 μm.  
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Figure 30. NCX1 immunosignal in the amygdala of NCX1ko and NCX1.4over mice. 
Immunofluorescence images showing amygdala of NCX1.4over (Over), NCX1.4+/+ (WT), 
NCX1ko (KO) and NCX1+/+ (WT) mice. Overview pictures and high-magnification 
photomicrographs showing the colocalization of NeuN (green: a, b, c, d) and NCX1 (red: e, f, 
g, h) in amygdala. Scale bars, 200 μm or 25 μm.  
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Figure 31. NCX1 immunosignal in ventral hippocampus of NCX1ko and NCX1.4over mice. 
Immunofluorescence images showing ventral hippocampus of NCX1.4over (Over), NCX1.4+/+ 
(WT), NCX1ko (KO) and NCX1+/+ (WT) mice. Overview pictures and high-magnification 
photomicrographs showing the colocalization of NeuN (green: a, b, c, d) and NCX1 (red: e, f, 
g, h) in ventral hippocampus. Scale bars, 200 μm or 25 μm. 
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Figure 32. NCX1 immunosignal in dorsal hippocampus of NCX1ko and NCX1.4over mice. 
Immunofluorescence images showing dorsal hippocampus of NCX1.4over (Over), NCX1.4+/+ 
(WT), NCX1ko (KO) and NCX1+/+ (WT) mice. Overview pictures and high-magnification 
photomicrographs showing the colocalization of NeuN (green: a, b, c, d) and NCX1 (red: e, f, 
g, h) in dorsal hippocampus. Scale bars, 200 μm or 25 μm. 
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Figure 33. pCREB_S133 immunosignal in cortex of NCX1ko and NCX1.4over mice. 
Immunofluorescence images showing cortex of NCX1.4over (Over), NCX1.4+/+ (WT), NCX1ko 
(KO) and NCX1+/+ (WT) mice. Overview pictures and high-magnification photomicrographs 
showing the colocalization of NeuN (green: a, b, c, d) and pCREB_S133 (red: e, f, g, h) in 
cortex. Scale bars, 200 μm or 25 μm. 
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Figure 34. pCREB_S133 immunosignal in amygdala of NCX1ko and NCX1.4over mice. 
Immunofluorescence images showing amygdala of NCX1.4over (over), NCX1.4+/+ (WT), 
NCX1ko (KO) and NCX1+/+ (WT) mice. Overview pictures and high-magnification 
photomicrographs showing the colocalization of NeuN (green: a, b, c, d) and pCREB_S133 
(red: e, f, g, h) in amygdala. Scale bars, 200 μm or 25 μm. 
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Figure 35.pCREB_S133 immunosignal in ventral hippocampus of NCX1ko and NCX1.4over. 
Immunofluorescence images showing ventral hippocampus of NCX1.4over (Over), NCX1.4+/+ 
(WT), NCX1ko (KO) and NCX1+/+ (WT) mice. Overview pictures and high-magnification 
photomicrographs showing the colocalization of NeuN (green: a, b, c, d) and pCREB_S133 
(red: e, f, g, h) in ventral hippocampus. Scale bars, 200 μm or 25 μm. 
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Figure 36. pCREB_S133 immunosignal in dorsal hippocampus of NCX1ko and NCX1.4over.  
Immunofluorescence images showing dorsal hippocampus of NCX1.4over (Over), NCX1.4+/+ 
(WT), NCX1ko (KO) and NCX1+/+ (WT) mice. Overview pictures and high-magnification 
photomicrographs showing the colocalization of NeuN (green: a, b, c, d) and pCREB_S133 
(red: e, f, g, h) in dorsal hippocampus. Scale bars, 200 μm or 25 μm. 
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Figure 37. pCaMKII_T286 immunosignal in cortex of NCX1ko and NCX1.4over mice.  
Immunofluorescence images showing cortex of NCX1.4over (Over) NCX1.4+/+ (WT), NCX1ko 
(KO) and NCX1+/+ (WT) mice. Overview pictures and high-magnification photomicrographs 
showing the colocalization of NeuN (green: a, b, c, d) and pCaMKII_T286 (red: e, f, g, h) in 
cortex. Scale bars, 200 µm or 25µm.  
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Figure 38. pCaMKII_T286 immunosignal in amygdala of NCX1ko and NCX1.4over mice. 
Immunofluorescence images showing amygdala of NCX1.4over (Over), NCX1.4+/+ (WT), 
NCX1ko (KO) and NCX1+/+ (WT) mice. Overview pictures and high-magnification 
photomicrographs showing the colocalization of NeuN (green: a, b, c, d) and pCaMKII_T286 
(red: e, f, g, h) in amygdala. Scale bars, 200 μm or 25 μm. 
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Figure 39. pCaMKII_T286 immunosignal ventral hippocampus of NCX1ko and 
NCX1.4over mice. 
Immunofluorescence images showing ventral hippocampus of NCX1.4over (Over), NCX1.4+/+ 
(WT), NCX1ko (KO) and NCX1+/+ (WT) mice. Overview pictures and high-magnification 
photomicrographs showing the colocalization of NeuN (green: a, b, c, d) and pCaMKII_T286 
(red: e, f, g, h) in ventral hippocampus. Scale bars, 200 μm or 25 μm. 
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Figure 40. pCaMKII_T286 immunosignal dorsal hippocampus of NCX1ko and 
NCX1.4over mice. 
Immunofluorescence images showing dorsal hippocampus of NCX1.4over (Over), NCX1.4+/+ 
(WT), NCX1ko (KO) and NCX1+/+ (WT) mice. Overview pictures and high-magnification 
photomicrographs showing the colocalization of NeuN (green: a, b, c, d) and pCaMKII_T286 
(red: e, f, g, h) in dorsal hippocampus. Scale bars, 200 μm or 25 μm. 
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Figure 41. Quantification of pCREB_S133 and pCaMKII286 expression in hippocampus of 
NCX1ko and NCX1.4over mice. 
(A) Quantification of pCREB_S133 in hippocampus of genetic modified mice NCX1ko (n=8), 
NCX1+/+ (n=8), NCX1.4over (n=8) and NCX1.4+/+ (n=8) normalized for total CREB and 
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expressed as percentage of control. §, p<0.05 vs congenic wild-type mice, unpaired 
Student’s t test. 
(B) Quantification of pKaMKII_T286 and pCaMKII_T305 in the hippocampus of genetic 
modified mice NCX1ko (n=8), NCX1+/+ (n=8), NCX1.4over (n=8) NCX1.4+/+ (n=8) normalized 
for tubulin and expressed as percentage of control. §, p<0.05 vs congenic wild-type mice, 
unpaired Student’s t test. 
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Figure 42. Quantification of pCREB_S133 and p CaMKII286 expression in cortex of NCX1ko 
and NCX1.4over mice. 
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(A) Quantification of pCREB_S133 in cortex of genetic modified mice NCX1ko (n=8), NCX1+/+ 
(n=8), NCX1.4over (n=8) and NCX1.4+/+ (n=8) normalized for total CREB and expressed as 
percentage of control. §, p<0.05 vs congenic wild-type mice, unpaired Student’s t test. 
(B) Quantification of pKaMKII_T286 and pCaMKII_T305 in cortex of genetic modified mice 
NCX1ko (n=8), NCX1+/+ (n=8), NCX1.4over (n=8) NCX1.4+/+ (n=8) normalized for tubulin 
and expressed as percentage of control. §, p<0.05 vs congenic wild-type mice, unpaired 
Student’s t test. 
 
  
87 
 
4.8 NCX1ko AND NCX1.4over MICE DO NOT DISPLAY IMPAIREMENT OF 
LOCOMOTOR ACTIVITY 
Locomotor activity of genetically modified mice were evaluated in the open field test 
and in rotarod test. In particular, NCX1ko mice did not show variations in total freezing 
time (Figure 43 A), total moving time (Figure 43 B), total distance travelled (Figure 43 
C), and in normalized speed (Figure 44B) in the open field test and latency to fall in 
rotarod test (Figure 44 D), as compared with congenic wild-type mice. By contrast, 
NCX1.4over mice, in open field, displayed an increase of the total freezing time (Figure 
43 D) with a reduction of both total moving time (Figure 43 E) and total distance 
travelled (Figure 43F) as compared with its congenic wild-type mice. On the other 
hand, no differences were observed in normalized speed (Figure 44 C) and in rotarod 
test (Figure 44 D).  
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Figure 43. Evaluation of locomotor activity in open field test. 
(A and D) Quantification of total time spent in freezing during open field test expressed in 
seconds in NCX1+/+ (31s ±3, n = 19), NCX1ko (29s ±5, n = 17) (A), NCX1.4+/+ (42s ±8, n = 
12), and NCX1.4over (80s ±13, n = 13) mice (D) expressed in seconds. §, p<0,05 vs 
respective congenic wild-type mice, unpaired Student’s t-test. 
(B and E) Quantification of total time spent moving in open field test in NCX1+/+ (215.35s ± 
5.89, n = 19), NCX1ko (196.71s ±7.01, n = 17) (B), NCX1.4+/+ (218.41s ± 10.39, n = 12), 
and NCX1.4over (181.65s ± 9.44, n = 13) (D) expressed in seconds. §, p<0,05 vs 
respective congenic wild-type mice, unpaired Student’s t-test. 
(C and F) Total distance travelled in the open field test in NCX1+/+ (12.976m ±0.829, n = 19), 
NCX1ko (10.957m ±0.653, n = 17) (C) NCX1.4+/+ (218.41s ± 10.39, n = 12), and 
NCX1.4over (181.65s ± 9.44, n = 13) (D) expressed in meters. §, p<0.05 vs respective 
congenic wild-type mice, unpaired student’s t test. 
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Figure 44. Evaluation of locomotor activity in open field and rotarod test. 
(A and B) Total distance travelled normalized for the total time spent moving expressed in 
meters per seconds in NCX1.4+/+ (0.09 m/s ± 10.39, n = 12) and NCX1.4over (181.65s ± 
9.44, n = 13) (A), NCX1+/+ (0.08 m/s ±0.01, n = 19) and NCX1ko (0.06 m/s ± 0.06, n = 17) 
(B).  
(C and D)  Average of time to fall in test session of rotarod task of NCX1.4+/+ (40.1s ±3.5, n = 
13) and NCX1.4over (40.2s ±4.3, n = 13) (C), NCX1+/+ (39.1s ±3.3, n = 18) and NCX1ko 
(34.2s ±2.9, n = 17) (D) mice expressed in seconds. 
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4.9 NCX1ko SHOW IMPAIRED, WHEREAS NCX1.4over MICE DISPLAY IMPROVED 
LONG-TERM MEMORY PERFORMANCE IN NOVEL OBJECT RECOGNITION, 
BARNES MAZE AND TRACE FEAR CONDITIONING TESTS 
The novel object recognition test allowed to evaluate spatial learning and memory by 
quantifying the time spent exploring a novel object 1h or 24h after a training session. 
During the training session both NCX1ko and NCX1.4over showed no preference for 
one object over another as compared with their congenic wild-type, suggesting that 
all experimental groups were equally motivated to explore each object (Figure 45). 
NCX1ko mice showed impaired spatial learning and memory as measured by the 
reduced time of exploration of novel object 1h and 24h after the training session 
(Figure 45 A). By contrast, NCX1.4over mice displayed an enhancement of time spent 
exploring the novel object after 24h as compared with its congenic wild-type 
littermates (Figure 45 B). In Barnes maze test, during the learning phase (trials 1-5), 
NCX1ko mice required more time than congenic wild-type to find the escape box in 
the last two days of the test (Figure 46 A). By contrast, NCX1.4over mice showed a 
slightly amelioration of long-term spatial memory in the last two days of the learning 
phase (Figure 46 B). 
In addition, in the memory recall phase (trial 6) the escape box was removed, the 
platform was virtually divided in 4 quadrants (Figure 47) and it was calculated the 
time spent in each one. NCX1ko mice spent less time in the quadrant of the platform 
that contained the escape box during the learning phase (Q1) (Figure 47 A) and 
displayed a reduced time of permanence in the probe zone (Figure 47 B). 
Accordingly, NCX1.4over spent more time in Q1 (Figure 47 C) and showed an 
increased time of permanence in the probe zone (Figure 47 D). 
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In the trace fear conditioning test, both NCX1ko and NCX1.4over mice increased 
freezing time after a single 0.8s foot-shock administered during the training trial 
(Figure 48).  
In addition, NCX1ko mice 30 minutes and 4 days after the training did not show any 
differences of freezing time than congenic wild-type in the same environment where 
they received the foot-shock (Figure 49 A and B). By contrast, NCX1.4over mice 
significantly increased their freezing time 30 minutes after foot-shock in the context 
trial (Figure 49 C). This effect was almost lost at 4 days where only the time segment 
180-240s was significant greater as compared with congenic wild-type (Figure 49 D). 
However, in a new environment (cue trial) NCX1ko, NCX1.4over mice and their 
respective congenic wild-type displayed an increased freezing time when exposed to 
the conditioned stimulus (sound) (Figure 50 A and B). 
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Figure 45. Impairment of memory performance for NCX1ko and improvement of memory 
performance for NCX1.4over mice in novel object recognition test 
(A) Mean exploratory preference during the training session and each retention time (1h and 
24h) in NCX1ko (n = 16) and congenic wild-type (n = 17) mice. Data are expressed as 
time spent exploring novel object versus total exploring time for both objects. *, p < 0.05 
vs respective group in training session, ANOVA followed by Student-Newman-Keuls 
post-hoc test; Genotype F(1,31)=7.7019, p=0.009; Time F(2,62)=6.1929, p=0.004;  §, p < 
0.05 vs congenic wild-type, Student’s t test. 
(B) Mean exploratory preference during the training session and each retention time (1h and 
24h) in NCX1.4over (n = 10) and congenic wild-type (n = 12) mice. Data are expressed as 
time spent exploring novel object versus total exploring time for both objects. *, p < 0.05 
vs respective group in training session, ANOVA followed by Student-Newman-Keuls 
post-hoc test; Genotype F(1,20)=0.00001, p=0.994; Time F(2,40)=1.5667, p=0.221;   §, p 
< 0.05 vs congenic wild-type, Student’s t test. 
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Figure 46. NCX1ko mice shows an impairment, whereas NCX1.4over mice display an 
improvement, of spatial learning performance during trial 1-5 of Barnes Maze. 
(A) Results of escape latency during trial 1-5 of Barnes maze in NCX1ko (n = 17) and 
congenic wild-type (n = 18) mice. Data are expressed in seconds. *, p<0.05 vs trial 1, **, 
p<0.05 vs trial 2, ANOVA followed by Dunn's post-hoc test in all pairwise multiple 
comparison procedure; Genotype F(1,29) = 4.7223, p=0.038; Time F(4,116) = 35.0442, 
p=0.000; §, p<0.05 vs congenic wild-type, unpaired Student’s t test. 
(B) Results of escape latency during trial 1-5 of Barnes maze in NCX1.4over (n = 20) and 
congenic wild-type (n = 19) mice. Data are expressed in seconds. *, p<0.05 vs trial 1, **, 
p<0.05 vs trial 2, ANOVA followed by Dunn's post-hoc test in all pairwise multiple 
comparison procedure. Genotype F(1,29) = 0.4033, p=0.530; Time F(4,116)=33.1803, 
p<0.0001. 
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Figure 47. NCX1ko mice shows an impairment, whereas NCX1.4over mice display an 
improvement, of spatial learning performance during trial 6 of Barnes Maze. 
(A and C) Quantification of the time spent by NCX1+/+ (33.8% ±2.4, n = 18) and NCX1ko 
(23.8% ±3.2, n = 17) (A), NCX1.4+/+ (20.9% ±3.2, n = 19) and NCX1.4over (33.4% ±2.4, n 
= 20) (C) mice in Q1 zone of the platform where before was located the escape box. 
Time is expressed as percentage of the total test duration. §, p < 0.05 vs respective 
congenic wild-type mice, unpaired Student’s t test. 
(B and D) Quantification of the time spent by NCX1+/+ (100% ±11) and NCX1ko (73% ±14) 
(B), NCX1.4+/+ (100% ±22) and NCX1.4over (183% ±18) (D) mice in the probe zone during 
trial 6, expressed as percentage of congenic wild-type mice. §, p < 0.05 vs respective 
congenic wild-type mice, unpaired Student’s t test. 
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Figure 48. Training trial of the trace fear conditioning test. 
(A and B) Freezing behavior of NCX1ko (n = 27) and NCX1+/+ (n = 28) mice (A), 
NCX1.4over (n = 30) and NCX1.4+/+ (n = 28) (B) during training session of trace fear 
conditioning test. Solid line indicates the duration of CS (tone, 15 s) and the triangle 
indicates US (foot-shock, 0.8s). *, p<0.05 vs all segments of time, ANOVA followed by 
Dunn’s in all pairwise multiple comparison procedure. 
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Figure 49. NCX1.4over mice display an improvement of memory performance in context trials. 
(A and B) Quantification of freezing behavior in the same environment where NCX1ko (n = 
27) and NCX1+/+ (n = 28) mice received the foot-shock 30 minutes before (A) and after 4 
days (B) from the traing phase.  
(C and D) Quantification of freezing behavior in the same environment where and 
NCX1.4over (n = 30) and NCX1.4+/+ (n = 28) mice received the foot-shock after 30 minutes 
(C) and after 4 days (D) from the traing phase. §, p<0.05 vs the corresponding time-
segment of congenic wild-type, unpaired Student’s t test. 
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Figure 50. Cued trace fear conditioning. 
(A and B) Quantification of freezing behavior, of NCX1+/+ (38.3% ±3.2, 71.7% ±3.3, n = 28), 
NCX1ko (37.4% ±3.7, 69.8% ±4.0, n = 27) (A), NCX1.4+/+ (30.7% ±2.6, 45.2% ±3.8, n = 
28), and NCX1.4over (31.6% ±3.6, 45.8% ±4.1, n = 30) (B) 60 minutes after training, in a 
new environment (represented by empty histograms) and in a new environment in 
presence of the acoustic stimulus (represented by full histograms). Data are represented 
as percentage of the session duration (180s). *, p < 0.05 vs respective basal conditions, 
paired Student’s t test 
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4.10 NCX1.4over MICE SHOW AN INCREASE IN ANXIETY SUSCEPTIBILITY IN 
OPEN FIELD, ZERO MAZE, BARNES MAZE, DARK/LIGHT BOX AND IN 
CORTICOSTERONE LEVELS 
The behavior of genetically modified mice was analyzed in open field and zero maze 
tests to evaluate their anxiety levels under basal conditions. The open arena of open 
field was virtually subdivided in three concentric zones and it was calculated the time 
spent in each one. NCX1ko mice showed no differences in the time spent in the 
external, intermediate and inner zone as compared to their congenic wild-type 
(Figure 51 A); whereas, NCX1.4over significantly spent more time in the external zone 
and less time in central zone (Figure 51 B).  
Moreover, NCX1ko showed no differences in time spent in open zone of zero maze 
(Figure 52 A), whereas NCX1.4over increased their residence time in the open zone 
(Figure 52 B), as compared to their respectively congenic wild-type littermates. 
In addition, during the trial 6 of Barnes maze, NCX1ko displayed increased time 
immobile in the inner zone of the platform (Figure 53 A and B) and NCX1.4over mice 
stayed significantly longer time in the external zone of the platform as compared to 
their congenic wild-type (Figure 53 C and D).  
In dark/light box test there was no difference in the total time spent in light zone 
between each genetic modified mouse, NCX1ko (Figure 54Figure 53 A) and NCX1.4over  
(Figure 54 B), and the respective wild-type group under basal conditions. However, 
NCX1.4over mice displayed a significant reduction of the time spent in the light zone 
after a single foot-shock (Figure 54 B). 
The corticosterone levels, evaluated in peripheral blood of mice, significantly reduced 
in NCX1ko (Figure 55 A) and increased in NCX1.4over (Figure 55 B) at 12:00 p.m. On 
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the other hand, no difference was observed at 6:00 a.m., 6:00 p.m. and 12:00 a.m. 
between genetic modified mice and their wild-type littermates. 
In addition, all experimental groups increased their corticosterone levels 1h after foot-
shock as compared to the pre-shock trial, whereas they returned to basal levels after 
24h (Figure 56). 
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Figure 51. NCX1.4over mice display an increased anxiety levels in open field test. 
(A and B)  Quantification of the time spent by animals in three concentric areas measured as 
anxious behavior test of NCX1+/+ (262s ±4, 31s ±3, 7s ±1, n = 19), NCX1ko (258s ±5, 33s 
±5, 9s ±1, n = 17) (A), NCX1.4+/+ (238s ±10, 52s ±9, 10s ±1, n = 12) and NCX1.4over 
(262s ±4, 32s ±4, 6s ±1, n = 13) mice (B). Time is expressed in seconds. §, p<0.05 vs 
respective congenic wild-type mice, unpaired Student’s t test. 
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Figure 52. NCX1.4over mice display an increased anxiety levels in zero maze test. 
(A and B)  Total time spent in the open zone of zero maze of NCX1+/+ (100% ±6.4, n = 
18), NCX1ko (100% ±7.7, n = 17) (A), NCX1.4+/+ (100% ±4.1, n = 12), and NCX1.4over 
(67.9% ±6.2, n = 13) (B) mice expressed as percentage of respective congenic wild-
type mice. §, p<0.05 vs respective congenic wild-type mice, unpaired Student’s t test. 
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Figure 53. NCX1.4over mice increase anxiety levels during the trial 6 of Barnes maze test. 
(A and C) Heat maps of mouse position on Barnes maze platform for NCX1ko (n = 17) and 
NCX1+/+ (n = 18) (A), NCX1.4over (n = 20) and NCX1.4+/+ (n = 19) (C) mice. 
(B) Quantification of the total immobile time spent by NCX1+/+ (20.8s ±5.7), NCX1ko (52.0 
±8.3), NCX1.4+/+ (16.7s ±3.6), and NCX1.4over (6.6s ±2.1) mice in the inner zone of 
Barnes maze platform during trial 6, expressed as percentage of test duration. §, p<0.05 
vs respective congenic wild-type mice, unpaired Student’s t test. 
(D) Quantification of the total time spent by NCX1+/+ (65.4s ±3.8), NCX1ko (59.1 ±4.6), 
NCX1.4+/+ (41.3% ±6.8), and NCX1.4over (67.0s ±4.4) in the peripheral zone of Barnes 
maze platform during trial 6, expressed as percentage of congenic wild-type. §, p<0.05 vs 
respective congenic wild-type mice, unpaired Student’s t test. 
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Figure 54. NCX1.4over mice display an increased anxiety levels in dark-light box after foot-
shock. 
(A) Quantification of total time spent in the light box by full body before the foot-shock (on the 
left) in NCX1+/+ (21% ±4, n = 12), NCX1ko (15% ±2, n = 10), and after foot-shock (on the right) 
in NCX1+/+ (18% ±8, n = 12), NCX1ko (14% ±5, n = 10). Time is expressed as percentage of 
total test time (5min). 
(B) Quantification of total time spent in the light box by full body before the foot-shock (on the 
left) in NCX1.4+/+ (25% ±7, n = 10), and NCX1.4over (14% ±3, n = 8) and after foot-shock (on 
the right) in NCX1.4+/+ (17% ±7, n = 10) and NCX1.4over (3% ±1, n = 8). Time is expressed as 
percentage of total test time (5min). §, p<0.05 vs congenic wild-type mice, unpaired Student’s 
t test; *, p<0.05 vs respective non-shocked group, paired Student’s t test. 
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Figure 55. Corticosterone levels measured during circadian rhythm. 
(A and B) Concentrations of serum corticosterone in NCX1ko and NCX1+/+ (A), NCX1.4over 
and NCX1.4+/+ (B) male mice at different time of day. §, p<0.05 vs respective congenic 
wild-type mice, unpaired Student’s t test 
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Figure 56. Corticosterone levels measured after foot-shock. 
(A) Concentration of serum corticosterone levels under basal conditions (12:00 p.m. of 
circadian rhythm) and 1h and 24h after the foot-shock in NCX1+/+ and NCX1ko mice. §, 
p<0.05 vs respective congenic wild-type mice, unpaired Student’s t test. *, p<0.05 vs 
respective control group, unpaired Student’s t test. 
(B) Concentration of serum corticosterone levels under basal conditions (12:00 p.m. of 
circadian rhythm) and 1h and 24h after the foot-shock in NCX1.4+/+ and NCX1.4over 
mice. §, p<0.05 vs respective congenic wild-type mice, unpaired Student’s t test. *, 
p<0.05 vs respective control group, unpaired Student’s t test, **, p<0.05 vs respective 
control group at 24h after foot-shock. 
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5. DISCUSSION 
The main conclusions of the present study are: (1) to have designed, synthetized and 
characterized a novel potent activator of NCX1, named compound 2; (2) NCX1 plays 
a role in some cognition processes such as spatial memory and anxiety response. 
  
5.1 THE ADDITION OF CLORYDE IN POSITION 2 ON NEUROUNINA 1 
SCAFFOLD LEDS TO THE GENERATION OF A NOVEL POTENT ACTIVATOR OF 
NCX1  
Different modifications on the chemical backbone of neurounina-1 were made to 
obtain novel compounds able to selectively affect each of the three different isoforms 
of NCX. From a preliminary screening, based on 45Ca2+ radiotracer assay and fura-2 
technique ( Figure 2), three groups of modifications emerged as most promising: the 
addition of chloride in position 2 or 7 and the elongation of molecular chain in position 
1 (Figure 1). In particular, molecules characterized by addition of chloride residue, 
compounds 2 and 3, showed an increased selectivity on NCX1 activity; derivatives 
generated by elongation of molecular chain in position 1, compounds II and IX, 
displayed inhibitory effects on NCX2 activity; compound III, generated by elongation 
of molecular chain in position 1, was chosen for its activator effects on NCX3 activity. 
More detailed experiments, such as concentration-effect curves, revealed that 
compound 2, was the most potent and selective modulator of NCX1 (Figure 3), 
whereas the other four compounds showed weak efficacy to regulate the activity of 
each NCX isoforms.  
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5.2 COMPOUND 2 AMELIORATES INDICES OF SPATIAL LEARNING AND 
MEMORY  
The effects of the five selected compounds were assessed in behavioral tests 
specific for cognition processes evaluation since some studies demonstrate 
importance of NCX2 and NCX3 in learning and memory performance (Jeon et al., 
2003; Molinaro et al., 2011). None of the new compounds showed neither in vitro 
toxicity, as measured by cell viability after 10 nM or 10  µM incubation, nor in vivo 
toxicity measured by body weight loss after one and two weeks of treatment (Figure 
6 A and B). 
In novel object recognition test, one of the most common behavioral test used for 
learning and memory performance (Ennaceur and Delacour, 1988; Leger et al., 
2013), compound IX ameliorated long term memory (Figure 11) accordingly to the 
results obtained in NCX2 knock-out mice (Jeon et al., 2003). Moreover, this 
compound also induced an increase of novel object exploration 1h after the training 
session as compared with vehicle-treated mice; this could be due to the effects of the 
temporally inhibition of NCX2 that increases paired pulse facilitation (PPF) and 
transient enhancement of neurotransmitter release; there are some pieces of 
evidence demonstrating that during to the novel object test there is an increase of 
neurotransmitter release in hippocampus during novel object recognition phase 
(Stanley et al., 2012). 
Compound III, the one selected as activator of NCX3, didn’t show any amelioration in 
novel object recognition test (Figure 12) probably because of its weak, and less 
selective, effects on NCX3 activity. 
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Interestingly, mice treated with compound 2 increased the exploration time of novel 
object in both 1h and 24h trials, even if, until now, there is no evidence for the role 
played by NCX1 in learning and memory processes (Figure 10).  
None of the selected compounds showed amelioration of escape time in Barnes 
maze test during learning phase. However, mice treated with compound IX or 2 
displayed an amelioration of spatial learning and memory performance during the 
memory recall phase. In particular, compound IX-treated mice increased the time 
spent in the probe zone suggesting improvement of spatial memory as compared 
with vehicle-treated mice (Figure 17). In addition, compound 2-treated mice displayed 
an increase of: (a) total time spent in the quadrant where was located the escape box 
(Q1), (b) total time spent in the probe zone, (c) number of entries in probe zone 
(Figure 16). Taken together these results suggest a strong consolidation of spatial 
memory for mice treated with compound 2.  
Also results obtained in trace fear conditioning test confirmed the consolidation of 
spatial memory for mice treated with compound 2 during the context trial performed 
30 minutes after the training, whereas compound IX didn’t induce amelioration of 
memory (Figure 19) possibly because of the low levels of NCX2 expression in the 
amygdala, a crucial brain region for this test (Kwapis et al., 2011; Baysinger et al., 
2012; Gilmartin et al., 2012). 
In conclusion of the first part of the present study, compound 2 was found to be the 
most promising, among all the new generated compounds, since it was able to 
ameliorate spatial learning and memory performance in mice. In addition, this could 
represent a starting point for the study of the role played by NCX1 in these cognition 
processes. 
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5.3 THE INCREASE OF NCX1 EXPRESSION/ACTIVITY INDUCES ACTIVATION 
OF CREB AND CAMKII  
To deeper investigate the improvement of memory dependent on NCX1 
expression/activity we analyzed typical molecular markers of memory, such as 
pCREB and pCAMKII_T286 in cortex, hippocampus and amygdala of all mouse 
groups. In particular, results obtained in NCX1 genetically modified mice suggest that 
NCX1 positively correlates with the activation of CaMKII/CREB molecular markers, 
possibly via intracellular Ca2+-dependent pathways (Ma et al., 2015). In addition, the 
activation of CREB, observed in the amygdala of NCX1.4over mice could be ascribed 
to the CaMKII activity, where they participate in a memory reconsolidation process 
(Jarome et al., 2016). 
 
5.4 NCX1 OVEREXPRESSION IMPROVES, WHEREAS NCX1 KNOCKOUT 
IMPAIRS LEARNING AND MEMORY PERFORMANCE 
Since it was observed that the activation of NCX1 improved spatial learning and 
memory performance and the increase of NCX1 activity or expression enhanced the 
phosphorylation of markers of memory, the role of NCX1 played in learning and 
memory process was deeper investigated. NCX1.4over and NCX1ko mice were 
subjected to several behavioral tests. Their motor coordination and locomotor activity 
were evaluated in open field and rotarod test (Bohlen et al., 2009; Tatem et al., 
2014). Among these mouse groups, only NCX1.4over mice significantly travelled less 
distance (Figure 43), probably because they spent more time in a freezing status 
since no differences was observed in normalized speed, calculated as the total 
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distance travelled during time mobile (Figure 44). Moreover, rotarod test displayed no 
differences in time latency to fall for all genetic modified animals.  
In novel object recognition test NCX1ko mice showed an impairment of memory 
hippocampus dependent as measured by novel object recognition test (Antunes and 
Biala, 2012), whereas NCX1.4over mice, in the same test showed a slight amelioration 
of reconsolidation memory. In addition, NCX1.4over mice showed an increased the 
time spent in the Q1 and the specific area in which previously was located the 
escape box suggesting a strong consolidation of spatial memory (Figure 47) during 
the memory recall phase. Opposite results were obtained with NCX1ko mice under 
the same conditions if compared with their congenic wild-type controls. In addition, 
these results were reinforced by similar data obtained in trace fear conditioning test 
suggesting an improvement of spatial memory for NCX1.4over mice. In line with these 
data, C57BL/6 mice treated with compound 2 showed an improvement of spatial 
memory under the same conditions. Nobably, both genetically modified mice for 
NCX1 and mice treated with compound 2 showed a significant increase of freezing 
time only in the same context where they received the footshock delivery 30 minutes 
before if compared with respective control group. On the other hand, the effect was 
almost lost at 4 days after footshock delivery. It is should be mentioned that the 
contextual memory evaluated by trace fear conditioning is dependent by the neural 
communication among amygdala, hippocampus and medial prefrontal cortex (Maren 
et al., 2013), three brain regions of NCX1.4over mice in which there is a significant 
increase of NCX1 expression (Figure 30). 
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5.5 NCX1 INCREASES ANXIETY LEVELS 
An increase of anxiety levels was observed in NCX1.4over mice subjected to open 
field, zero maze, Barnes maze and dark/light box test. In particular, NCX1.4over mice 
spent significantly more time in the external zone in open field, avoiding the open 
zone in the zero maze test and the central region of Barnes maze platform during 
trial 6. On the other hand, these results were not observed in C57BL/6 mice treated 
with compound 2 probably because the acute effect compared to the chronic 
increased expression/activity of NCX1 in genetic modified mice. Thus, in the case of 
the treatment with compound 2 it would be necessary a stimulus for the occurrence 
of anxiety dependent by NCX1. In fact, it was observed an increase of anxiety levels 
comparable for both mouse groups in the dark/light box test performed after the foot-
shock delivery. 
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